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PREFACE
The work described in this thesis was per­
formed during my tenure of a British Heart 
Foundation and Anerican Heart Association British- 
American Exchange Fellowship, September 19^7 - 
August 1968.
The Fellowship was based in the Section on 
Lipoproteins, Laboratory of Molecular Disease, 
National Heart Institute, Bethesda, Maryland, U.S.A# 
(Director - Dr# Donald S* Fredrickson)#
The general aspects of the project were out­
lined to me, on my arrival, by Dr. Robert I* Levy, 
Head of the Section on Lipoproteins# The sub­
sequent planning of the investigation and its daily 
pursuit were ray responsibility* Periodically its 
evolution was discussed with Dr. Levy* Except 
where specifically acknowledged, all the investi­
gations described in this thesis were carried out 
personally.
D E P A R T M E N T  OF H E A LT H . ED U C A TIO N , A N D  W E LFA R E
■ PUBLIC HEALTH SERVICE
lO NAL IN S T IT U T E S  OF H E A LTH  
BETHESDA. MO. 20014 
\ CODE 301 TEL; 656-4000
To whom it may concern:
Dr. Basil Rifkind has been a Visiting Scientist in the Molecular 
Disease Branch o£ the National Heart Institute for the past year. During 
this time he has participated in some of our patient care activities.
He has directed a majority of his time toward the investigation of 
the lipoprotein abnormalities that occur in obstructive liver disease. 
With guidance, essentially all of Dr. Rifkinds work, both immunochemical 
and chemical, has been done by him, for the most part without technical 
assistance.
Dr. Riflcind has succeeded in assembling some new information regard­
ing the nature of lipoprotein complexes and lipoprotein abnormalities 
that occur in obstructive liver disease. These observations, I am sure, 
will contribute substantially toward our understanding of the seemingly 
paradoxical plasma lipid abnormalities previously reported in liver 
disease.
Please feel free to contact us if you have any questions.
Sincerely yours,
Robert I, Levy, M.D.
Head, Section on Lipoproteins 
Deputy Clinical Director 
National Heart Institute
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1. Alpha lipoprotein levels have been variously 
described as increased or decreased in the plasma 
of subjects with jaundice due to intra- or extra»* 
hepatic biliary obstruction, including biliary 
cirrhosis, the findings varying with the method 
used*
2* To resolve this paradox, a chemical and immuno­
chemical study of the changes that occurred in the 
plasma lipids and lipoproteins of 21 subjects with 
various types of obstructive jaundice was performed* 
Three patterns of lipoprotein disturbances were 
recognised*
3o In 9 subjects an abnormal alpha lipoprotein 
form was detected by immunoelectrophoretic and immuno­
diffusion studies within the d 1*006 - 1*063 fraction, 
together with beta lipoprotein* This low density 
alpha lipoprotein displayed cathodal or retarded 
electrophoretic mobility in agar and agarose gels 
respectively, and abnormal features in immunodiffusion 
studies* These subjects also showed, on paper 
electrophoresis/
— 2 —
electrophoresis of their d I.OO6 - I.O63 
fraction, an additional lipoprotein hand mig­
rating between the origin and the beta lipo­
protein band, or cathodally; this band 
displayed unusual staining characteristics in 
that it usually stained for protein but not for 
lipid although the latter was shoim to be 
present* It is thought to correspond to the 
abnormal alpha lipoprotein detected on immuno- 
electrophoresis* These abnormalities dis­
appeared with relief of jaundice*
4. An abnormal alpha lipoprotein form was also 
detected at d 1*006 - I.O63 in the plasma of 2 
subjects; unlike the previous form it showed normal 
electrophoretic mobility in agarose and agar gels, 
and in paper in which it stained for lipid and for 
protein. Its immunodiffusion characteristics were 
unaltered.
3, In 10 subjects alpha lipoprotein was not iden­
tified outwith its normal density class, and in this 
group/
- 3 -
group elevated levels of beta lipoprotein of 
altered composition were found establishing the 
occurrence of a pure hyperhetalipoproteinaemia,
6* Quantitative studies of the plasma lipid 
and lipoprotein levels, and of lipoprotein com­
position showed several significant differences 
between the groups, with the maximum disturbances 
occurring in the subjects with the low density 
alpha lipoprotein of altered electrophoretic 
mobility*
7o On the basis of these findings it is suggested 
that the appearance of alpha lipoproteir forms of 
abnormally low density, with or without altered 
electrophoretic mobility, results from the over- 
lipidation of alpha lipoprotein secondary to biliary 
obstruction,
8, The demonstration of an alpha lipoprotein form 
of low density, altered electrophoretic mobility 
and unusual staining properties resolves the previous 
conflicting reports regarding alpha lipoprotein 
changes/
- 4 -
changes in obstructive jaundice.
9# A lipoprotein of beta mobility was found 
within the d < I.OO6 fraction of 11 subjects, 
similar to the "floating" beta lipoprotein of 
familial Type III hyperlipoproteinaemia.
10* Subjects with jaundice due to extra- or intra- 
hepatic biliary obstruction could not be distin­
guished from those with biliary cirrhosis by their 
lipid and lipoprotein abnormalities©
NOMENCLATURE
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The plasma lipoproteins are usually 
classified in operational terms (Table 1*1 and 
see Chapter l) according to their electrophor­
etic mobility on paper (Lees and Hatch, I963), 
or their density characteristics as exploited 
by use of the preparative ultracentrifuge, or 
their flotation properties as measured in the 
analytical ultracentrifuge*
The 4 major lipoprotein classes defined by 
any of these systems broadly correspond to those 
defined by the other systems (Hatch et al, 1967)0 
Although such classifications have consider­
able validity, are usually interchangeable, are 
generally accepted and have been of great use, 
they are limited in their failure to provide an 
entirely adequate division which reflects the 
metabolic interrelationships between the various 
classes (Schumaker and Adams, 1969). Another 
major deficiency of operational classifications has 
been/
been recognised with the recent demonstrations 
that lipoproteins with altered physico-chemical 
properties occur in certain diseases. For 
example, in familial Type III hyperlipoprotein— 
aemia ("broad beta" disease), a lipoprotein with 
the electrophoretic mobility of beta lipoprotein 
is found at d < 1*006 (Fredrickson et al, 1967). 
Similarly a small amount of beta lipoprotein has 
been found to float at d 1.006 in subjects with 
Tangier Disease or Hereditary High Density Lipo­
protein Deficiency (Fredrickson et al, I967). 
Likewise, in abetalipoproteinaemia, alpha lipo­
protein has been identified, on the basis of its 
immunochemical specificity and its amino-acid 
composition, within the density range 1.019 - I.O63, 
normally solely occupied by beta lipoprotein (Levy 
et al, 1966).
With this in mind the following nomenclature 
has been adopted for the present study. The 
abbreviations VLDL, LDL and HDL refer only to any 
lipoproteins/
— 7 —
lipoproteins observed within the density classes 
< 1,006, 1*006 - 1,063 and > 1,063 respectively; 
they do not define particular lipoprotein classes. 
The terms chylomicrons, beta, pre-beta and alpha 
lipoproteins define the 4 major classes of lipo­
proteins with properties conforming to those set 
out in Table 1*1 except where evidence is presented 
for alteration in one or more of these properties* 
An exception to this nomenclature is when the 
findings of other workers are described, when the 
terminology employed by them has been retained*
This has been necessary since in some reports the 
lipoproteins are defined purely on the basis of the 
method used to study them and it has occasionally 
proved difficult to translate the lipoprotein class 
as defined by a given worker into the nomenclature 
adopted in the present paper*
SECTION I
INTRODUCTORY REVIEW
CHAPTER I
THE PLASMA LIPOPROTEINS:
THEIR PROPERTIES AND FUNCTIONS
—• 8 —•
This chapter classifies the plasma lipoproteins, 
gives a detailed account of each of them and presents 
current views of their major functions. It is not 
meant to provide a comprehensive description of all 
aspects of the plasma lipoproteins, but attempts to 
set them in perspective, emphasising those features 
which are or may be of relevance in understanding 
the changes which occur in obstructive jaundice and 
biliary cirrhosis.
- 9 -
Plasma lipids The major plasma lipids are free 
cholesterol, cholesterol ester, triglyceride and 
phospholipid* The functions of these various plasma 
lipids still remain to he fully comprehended (Nichols, 
1969)0 Free cholesterol is found in almost all 
tissues* It is a precursor of the steroid hormones 
and of the hile acids. Its presence in many cell 
membranes suggests a structural role there# Chol­
esterol ester is mainly found in the plasma, liver 
and adrenal glands# Its function is obscure (Goodman, 
1965). In man, in harmony with many species, the 
proportion of plasma cholesterol maintained in ester 
form is remarkably constant (Goodman, 1965)*
Triglyceride participates in energy metabolism; 
on hydrolysis it yields free fatty acids which are 
utilised by various tissues including skeletal and 
cardiac muscle as a major source of energy* Fatty 
acid released from triglyceride and not oxidised may 
be re-esterified in liver or in adipose tissue ulti­
mately providing û reservoir of free fatty acid in 
the form of stored glyceride*
The/
- 10 -
The phospholipids are found in many cellular 
and subcellular membranes where they appear to have 
a structural role. Their amphipathic properties with 
their tendency to orientate at lipid-water interfaces 
are strongly suggestive of a stabilising, influence on 
lipoprotein complexes.
Transport tasks of lipoproteins Considerable amounts 
of lipid require to be transported through the plasma, 
Fredrickson (1969) has estimated the net daily trans­
port of the various lipids in the adult; 70 - 150 G 
of exogenously derived triglyceride pass through the 
plasma each day in a series of fluxes following the 
ingestion of triglyceride-containing meals. The turn­
over of endogenous triglyceride, mainly of hepatic origin 
is about 25 - 50 G/day. The daily turnover of free and
ester cholesterol is approximately 1 G,
The solubilisation of highly apolar lipids such as 
triglyceride, cholesterol and cholesterol ester in aqueous 
plasma is achieved by the formation of macromolecular 
complexes called lipoproteins.
Plasma lipoproteins Four major lipoprotein classes 
are/
- 11 -
are generally recognised in the normal subject. They 
are usually defined in operational terms (Table l.l). 
According to their mobility during electrophoresis on 
paper they are described as beta lipoproteins, pre­
beta lipoproteins and alpha lipoproteins; the 4th 
class, the chylomicrons, fails to migrate on paper 
(Lees and Hatch, I963). Alternatively, they may be 
separated according to their differing densities, 
using the preparative ultracentrifuge (Havel et al, 
1955) into 4 classes, corresponding to those defined 
by electrophoresis and named low density lipoproteins 
(LDL), very low density lipoproteins (VLDL), high 
density lipoproteins (HDL) and chylomicrons. A 3rd 
system classifies them according to their behaviour in 
the analytical ultracentrifuge; they are assigned 
Sjp values (Lindgren et al, 1951 > DeLalla and Gofman, 
1954) which express their rate of flotation per unit 
centrifugally in a solution of sodium chloride (density 
1.063) at temperature 26°,
In addition to these 4 generally recognised lipo­
protein classes, there may exist a lipoprotein of
v
" 12 —'
d > 1.21 ("very high density lipoprotein”) (Fredrick­
son et al, 1967).
Plasma from a healthy fasting subject contains 2 
major lipoproteins, the beta and alpha lipoproteins.
Beta lipoprotein (LBL, 0 - 20 lipoprotein)
The beta lipoproteins migrate with the mobility 
of beta globulin in various electrophoretic media 
including paper (Lees and Hatch, I963)* They occupy 
the density range 1,006 to I.O63 (DeLalla and Gofman, 
1934). Their lipid and protein composition, expressed 
as a percentage of the dry weight of the total lipo­
protein is shown in Table 1.2. Almost half of the 
complex consists of cholesterol of which about SOfo is 
esterified (Goodman, 1963). The balance consists of 
about equal amounts of protein and phospholipid (approx­
imately 22^ of each) and a small amount of triglyceride. 
These figures do not include the carbohydrate moiety 
which is also present in beta lipoprotein (Marshall and 
Kummerow, 1962) and whose significance is undetermined. 
The protein moiety of beta lipoprotein (apoprotein 
B) is thought to consist of several identical or similar 
polypeptides characterised by carboxyterminal serine and 
aminoterminal/
- 13 -
aminoterminal glutamic acid and by a total amino 
acid composition which is quite different from that 
of the HDL apoprotein (Fredrickson et al, 196?, Oncley 
and Harvie, 1969),
Structural studies have been hampered by the 
difficulty in obtaining a delipidated apoprotein 
which retains its aqueous solubility, the stripping 
of lipid from the complex resulting in a gel-like 
material insoluble in water or urea (Gotto, I969). 
Recently various chemical modifications of the apo­
protein such as succinylation and/or the use of 
detergents such as sodium dodecyl and decyl sulphate 
have yielded essentially lipid free apoproteins (see 
Gotto, 1969 for summary of these methods). The 
soluble apoprotein of low density lipoprotein (apoLDL) 
retains prominent immunological and optical character­
istics of native LDL (Gotto, I969). The conformation 
of LDL has been investigated using optical methods 
such as infra-red and circular dichroic spectroscopy. 
They have revealed a significant amount of pleated 
sheet anti-parallel chain, beta-structure with some 
random/
- 14 -
random and, probably, alpha helical structure 
(Gotto et al, 1968)*, Delipîdation results in 
an increase of random structurée
A primarily spherical form of mean diameter 
216 & with no specific suh-unit structure has been 
proposed for beta lipoprotein (Nichols, 1969) on the 
basis of electron microscopy. Different electron 
microscopic findings have been described by 
Pollard et al (1969) who on the basis of ultra­
centrifugal and electron microscopic studies of 
human LDL and several of its derivatives, have 
formulated a model of the lipoprotein in which 
20 protein sub-units are arranged in a dodecahedrol 
pattern with icosahedrol symmetry. The lipoprotein 
surface is held to be occupied by both protein and 
lipids, especially phospholipid, with apolar lipids 
(cholesterol esters and triglyceride) in the interior 
of the molecule.
Beta lipoprotein is strongly antigenic, even 
trivial amounts stimulating the production of a 
potent antibeta lipoprotein antiserum (Fredrickson 
et al, 1967). Purified agar or agarose (sulphate- 
free/
- 13 -
free agar) provide the hest media for immuno­
chemical studies of beta lipoproteins; other 
media suffer from the disadvantage of inter­
acting with the lipoprotein.
Antisera to the beta apoprotein either form 
lines of complete identity with beta lipoprotein 
and the beta apoprotein or detect very minor differ­
ences suggesting that the protein is the major 
immunochemical determinant (Gotto, 1969). Neverthe­
less, antisera to heta lipoprotein produce only lines 
of partial identity between beta lipoprotein and the 
beta apoprotein and it has been suggested that delipid- 
ation leads to the removal of haptenic reactants or to 
conformational changes in the peptide.
Beta lipoprotein probably originates in the liver 
and the intestine (Windmueller and Levy, 196?) but may 
solely or partially appear in the plasma as a product of 
pre-beta lipoprotein metabolism, A precursor-product 
relationship between pre-beta lipoprotein and beta 
lipoprotein has been shown by kinetic studies of low 
density lipoproteins, and during the acute in vivo 
hydrolysis/
- l6 -
hydrolysis of pre-heta lipoprotein induced hy the 
intravenous administration of heparin, lipoprotein 
products are released including one with the ultra- 
centrifugal, paper electrophoretic and chemical 
composition of heta lipoproteins (Nichols et al,
1968).
Beta lipoprotein or its apoprotein is not 
uniquely confined to the low density fraction 
hearing its name; it is also identifiable, follow­
ing delipidation, in pre-beta lipoproteins (Levy et 
al, 1966) and is probably a constituent of chylo­
microns (Fredrickson et al, 196?).
Alpha lipoprotein (iIDL)
Alpha lipoproteins have alpha^ mobility on free 
electrophoresis and in media such as paper and starch. 
They are isolated within the density range I.O63 - 
1,21. They have been sub-divided into HDL^ (d I.O63 - 
1,12) and HDL^ (d 1,12 - l,2l) sub-classes (DeLalla 
and Gofman, 1934), but the latter may be artefactually 
derived from the former (Levy and Fredrickson, I963)* 
Unlike the other lipoproteins of lower density they 
are/
“ 17 —
are not precipitated by polyanions such as heparin 
but remain in the supernate, a property which is 
exploited for their quantitation (Burstein and Sam- 
aille, i960).
The lipid and protein composition of alpha 
lipoprotein is shoim in Table 1,2. About 50^ of 
the complex is protein; the balance consists of 
approximately 30^ phospholipid and 18^ cholesterol, 
about 80^ of which is esterified, and a small amount 
of triglyceride. The protein moiety also contains 
over 3^ carbohydrate by weight (Epstein and Block,
1959).
It was formerly considered that the protein 
moiety of alpha lipoprotein (apoprotein A) solely 
consisted of polypeptide sub-units containing amino­
terminal aspartic acid and carboxyterminal threonine 
(apoHDL-Thr) (Shore, 1957)o Recently an additional 
polypeptide with carboxyterminal glutamine (apoHDL-Gln) 
has been described (Shore and Shore, 1968), Approxi­
mately equal amounts of apoHDLr-Thr and apoHDL-GIn 
account for over 90^ of the protein of HDL^,
Optical/
- 18 -
Optical studies of native HDL show it to he 
rich in alpha-helical conformation (Gotto, I969). 
Circular dichroic measurements of apoHDL-GIn and 
apoHDL-Thr show the former to contain considerably 
less alpha-helical structure (40-50^) than the 
latter ( > 90^). These results inversely correlate 
with the content of certain non-helical aminoacids 
in the peptides (Gotto and Shore, 1969)0 It has 
been postulated that apoIH)Ir-Gln may be particularly 
involved in the binding of HDL lipid (Gotto, 1969; 
Gotto and Shore, I969)*
Cross-reacting antisera can be prepared against 
alpha lipoprotein or its soluble apoprotein. Alpha 
lipoprotein is less potent than beta lipoprotein in 
stimulating the production of antisera, perhaps re­
lated to its lower lipid content. It is difficult 
to obtain a completely pure preparation of alpha 
lipoprotein since antisera raised against typical 
preparations often display additional anti-beta 
lipoprotein reactivity (Fredrickson et al, 196?)• 
However, it is generally agreed that alpha lipoprotein 
is/
— 19 —
is antigenically distinct from beta lipoprotein 
(Fredrickson et al, 196?, Margolis, 1969)0 Fresh 
plasma normally contains a single immunological form 
of alpha lipoprotein. Following recent storage or 
various laboratory manipulations of plasma, an 
additional slower migrating form appears on immuno- 
electrophoresis of the plasma. Levy and Fredrickson 
(1965) have designated these two alpha lipoprotein 
forms as alpha LP^ and alpha LP^ respectively, 
suggesting that the latter represents a partially 
delipidated alpha lipoprotein containing a smaller 
polymer of the basic sub-unit of the apoprotein.
On electron microscopy, alpha lipoprotein 
displays aggregates consisting of 4 - 6 spherical 
sub-units (Nichols, 1969)0
The biological half-life of alpha lipoprotein 
is about 4 days, similar to that of beta lipoprotein, 
considerably slower than that of chylomicrons or pre­
beta lipoproteins but faster than that of almost all 
the other plasma proteins (Gitlin et al, 1938).
Alpha lipoprotein or its protein moiety is also
not/
- 20 -
not specific to the high density lipoprotein class 
hearing its name. It is also identifiable in and 
may stabilise pre-beta lipoprotein, and may be a 
component of chylomicrons (Fredrickson et al, I967).
A congenital and complete deficiency of normal 
alpha lipoprotein is found in the recessively inher­
ited disorder, Tangier Disease; the striking storage 
of cholesterol ester which occurs in the reticulo­
endothelial system of affected individuals suggests 
that alpha lipoprotein has a lipid transport function 
especially relating to cholesterol. Recently 
additional functions have been postulated for HDL or 
its apoprotein; it has been suggested that bound 
apoprotein A activates lipoprotein lipase and the 
lecithin:cholesterol acyl transferase enzyme (Schu- 
maker and Adams, I969).
Chylomicrons (s^ 400)
Chylomicrons (Gage, 1920) are defined as parti­
culate fat of alimentary origin (Dole and Hamlin,
1962). Their electrophoretic mobility varies accord­
ing to the medium used and according to whether they 
are/
“•21 —
are derived from plasma or lymph (Frazer, 1949, Kunkel 
and Slater, 1952). On electrophoresis in paper, 
employing albumen-containing buffer, the chylomicrons 
remain at the origin (Lees and Hatch, 1963)0
Chylomicrons are of d < 0.95 and are the light­
est lipoprotein class. They are assigned an S^ value 
greater than 400, It is not possible to distinguish, 
using the above criteria, the smallest chylomicrons 
from the largest pre-beta lipoproteins. Their low 
density reflects their exceedingly high lipid and low 
protein content. The precise nature of their pro­
tein component has been difficult to establish since 
some or all of the proteins observed may merely have 
been absorbed on to the surface of the particles when 
they enter lymph and plasma, analogous to the similar 
proteins acquired by a coconut oil emulsion following 
its incubation in plasma (Scanu and Page, 1959). 
However,“it is now generally held that both alpha and 
beta lipoproteins (or their apoproteins) are constit­
uents of chylomicrons (Fredrickson et al, 196?)o The 
postulated structural role of beta lipoprotein in 
chylomicrons/
- 22 -
chylomicrons is considerably strengthened by the 
observation that subjects with a congenital defi­
ciency of beta lipoprotein (abetalipoproteinaemia) 
are unable to form chylomicrons (Farquhar and Ways, 
1966)0
Chylomicrons have a spherical shape on electron 
microscopy and a diameter ranging from 1,200 - 11,000 
5 although most of the triglyceride is found in par- 
tides of 1,500 - 4,000 1 (Nichols, 1969). The 
particles are rapidly cleared from the plasma, dis­
playing a biological half-life of 5 — 15 minuteso 
The major clearance pathway involves a hydrolytic 
step which does not take place in the plasma but 
which appears to occur on the endothelial surface 
of capillaries under the influence of lipoprotein 
lipase (Havel, 1965)o This enzyme which can be made 
to appear in the plasma shortly after the injection 
of small amounts of heparin, splits the triglyceride 
into glycerol and fatty acids* Recent studies 
suggest that lipoprotein lipase activity represents 
the net activity of several enzymes, a monoglyceride 
lipase/
- 23 -
lipase having been described in addition to the 
classical triglyceride lipase (Greten et al, 1969)© 
Pre—beta lipoprotein (\TjDL, 20 -  400)
Pre-beta lipoprotein migrates with alpha^ 
globulin on electrophoresis in starch or paper, is 
found between d 0.93 - I0OO6, and has an value 
of 20 — 400o As mentioned previously there is 
overlap between the largest pre-beta lipoprotein 
particles and the smallest chylomicrons with respect 
to some of these characteristics. When pre-beta 
lipoprotein concentration rises the particle size 
increases and material described as "trail” is 
found on paper electrophoresis migrating from the 
pre-beta zone towards the origin (Lees and Hatch,
1963)0
Pre-beta lipoproteins are also rich in tri­
glyceride which, in contrast to that of the chylo­
microns, is mainly endogenously derived, the 
predominant source being hepatic synthesis from 
fatty acid or carbohydrate precursors. Triglycer­
ide accounts for approximately 65^ by weight of 
pre—beta/
“ 24 —
pre-beta lipoprotein, the amount rising as the 
particle size increases. Cholesterol accounts for 
approximately 13^, protein 10^ and phospholipid 12^ 
(Table 1*2), The fatty acid composition of trigly­
ceride differs from that of chylomicron triglyceride 
and is that of endogenously synthesised fat (Bierman 
et al, 1965)0
The protein moiety of pre—beta lipoprotein is 
currently the object of considerable study. Formerly, 
beta lipoprotein (or its apoprotein) was regarded as 
the main protein component. Levy et al (1966) sub­
sequently showed that, following careful delipidation 
of VLDL, alpha lipoproteins were also detectable by 
immunochemical means. The alpha^ electrophoretic 
mobility of this class has been attributed to the 
addition of the faster moving alpha lipoprotein to 
the beta lipoprotein containing complex.
Recently it has been demonstrated that about 50^ 
of the protein in VLDL does not consist of the alpha 
and beta lipoprotein apoproteins, and 2 additional 
polypeptides/
—  25 —
polypeptides characterised as carboxyterminal valine 
and carboxyterminal alanine VLDL apolipoproteins 
have been described (Bro\m et al, 1969)0 A 5th 
polypeptide, carboxyterminal glutamine VLDL apolipo­
protein, has just been reported (Bro^m et al, 1970),
CHAPTER 2
DISORDERED PLASMA LIPIDS AND LIPOPROTEINS IN 
OBSTRUCTIVE JAUNDICE
— 26 *“
An account of the changes which have been 
described in subjects with extra-hepatic biliary 
obstruction and biliary cirrhosis is given in 
this chapter. Certain of the findings are dealt 
with in expanded detail in Chapters 6, 7 and 10,
- 27 -
The first link between disordered lipid 
metabolism and hepatic disease seems to have 
been forged by Thomas Addison and William Gull 
(I851) who described "A Certain Affection of the 
Skin” described as "Vitiligoidea” which occurred 
in two forms "Plana” and "Tuberosa”. The skin 
lesions are well illustrated and would now be 
regarded as tuberous and planar xanthomata and 
xanthelasma* They associated the lesions with 
"hepatic derangement” and the details given suggest 
that this took the form of obstructive jaundice.
Eleven years later Austin Flint Jr, (I862) 
published experimental studies which led him to 
conclude that "cholesterine” was normally separated 
from the blood by the liver, to be excreted with 
the bile into the alimentary canal. The retention 
of cholesterine in the blood, "cholesteremia", he 
suggested was due to extensive structural disease 
of the liver, but he noted that, in some cases of 
"simple jaundice" (in retrospect, probably obstruct­
ive in type) cholesteremia also occurred.
In/
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In I9I8 Feigl showed the increase in serum 
cholesterol to he due mainly to an increase in 
free cholesterol so that the ratio of free rester 
cholesterol was increased,
A profile of the lipid disturbances in biliary 
obstruction and biliary cirrhosis was provided by 
Man et al (l945). They found total cholesterol 
and lipid phosphorus, especially the latter, to be 
raised in obstruction and to return to normal 
following its relief. High levels of these lipids 
were also observed in some cases of biliary cirr­
hosis and in the early obstructive phase of 
infective hepatitis. Neutral fat levels, determined 
by difference, were usually above normal, sometimes 
greatly so in obstructive jaundice. Free cholesterol 
levels were absolutely increased and also relative 
to cholesterol ester levels, which were usually dim­
inished and which rose as obstruction was relieved* 
These observations were confirmed and extended 
as reviewed by Ahrens et al (l950). In patients 
with/
- 29 -
with biliary cirrhosis they found preponderant 
elevations of phospholipid levels. They remarked 
on the characteristic clarity of the sera of such 
patients despite great increases in lipid levels, 
and attributed it to the high phospholipid levels 
and the surfactant properties of this lipid class. 
The xanthomata observed in many of their patients 
were clearly sho^m to be a consequence of the 
hyperlipidaemia rather than its cause, a view for­
merly propounded by Thannhauser (l940).
Kunkel and Ahrens (1949) presented evidence 
for the transport forms of these elevated lipids, 
suggesting that they were carried with the beta 
globulins. Using free electrophoresis they found 
marked increases in the beta globulin components 
in the serum of 8 patients with biliary cirrhosis. 
Beta globulin levels were directly proportional to 
the total serum lipid concentration over a wide 
range of lipid levels. Partial delipidation of the 
serum resulted in a marked reduction in the beta 
globulin/
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globulin components; the amount of lipid removed 
by this procedure relative to protein was greater 
than normal, providing the first hint that lipo­
protein composition was disturbed in biliary 
cirrhosis* Sterling and Ricketts (l949) obtained 
similar results.
Later Kunkel and Slater (l932) applied the 
technique of zonal electrophoresis on starch to the 
study of lipoproteins and found, in 5 cases of 
biliary cirrhosis with hyperlipidaemia, a very high 
peak composed mainly of phospholipid and which 
migrated with an electrophoretic mobility approxi­
mately similar to normal beta lipoprotein. They 
also described a great reduction or complete absence 
of the alpha lipoprotein peak in the subjects and 
in 2 others with extra-hepatic obstructive jaundice. 
They suggested that the low cholesterol-phospholipid 
ratio of the beta component might be due to a new 
lipoprotein migrating with the same mobility as 
normal beta lipoprotein, or more likely, to beta 
lipoprotein/
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lipoprotein having an altered lipid composition. 
Preliminary experiments suggested a lipid-protein 
ratio in this abnormal peak close to but slightly 
higher than that of normal beta lipoprotein.
The analytical ultracentrifuge was used to 
further define the lipoprotein abnormalities by 
McGinley et al (l952)o A unique pattern was found 
characterised by hugh increases of 6 and 8 
classes with a varying increase in the 8^ 10 - 17 
lipoproteins and a sharp cut off at 17. They 
alluded to, but did not provide evidence for, the 
possibility that the 6 and 8 classes had a 
different structure and chemical composition from 
normal,
Eder et al (l955), in a detailed study, 
provided firm evidence for disordered lipoprotein 
composition in biliary cirrhosis and obstructive 
jaundice. An interesting paradox was also revealed 
by their work in that, depending on the method used, 
alpha lipoproteins were found to be high or low. 
They/
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They used the Cohn fractionation procedure, method 
no* 10 (Cohn et al, 1950) to obtain fraction IV,
V and VI, which normally houses alpha lipoprotein, 
and fraction I and III which normally houses beta 
lipoprotein. They showed a number of changes in 
the lipoproteins of both fractions.
The increased total serum cholesterol of their 
subjects tended to accumulate in fraction IV, V and 
VI. This fraction had a normal cholesterol:phos- 
phorus ratio but all the cholesterol was in the free 
form. Normally alpha lipoprotein has a higher pro­
portion of its cholesterol in the ester form compared 
with beta lipoprotein. On paper and on starch this 
fraction migrated with the mobility of beta globulin, 
alpha lipoprotein being negligibly small, though it 
rose with relief of the disease. In the preparative 
ultracentrifuge most of the fraction floated at 
d 1*063 having apparently acquired the flotation 
characteristics of beta lipoprotein. In summary 
by the Cohn fractionation procedure, alpha lipoprotein 
was/
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was increased but it neither showed its normal 
electrophoretic or ultracentrifugal character­
istics, behaving as beta lipoprotein in these 
respects.
Fraction I and III showed the following 
changeSo The cholesterol:phospholipid ratio 
was markedly reduced often to a level character­
istic of fraction IV, V, VI* The ratio of free: 
ester cholesterol was markedly increased though 
not to the same extent as in the other fraction*
These changes were reverted to normal with relief 
of jaundice* The fraction otherwise exhibited 
the usual characteristics of beta lipoprotein 
migrating typically on paper and floating at d l*063c
The atypical lipoproteins were further examined 
by Russ et al (1956) in a single case of xanthoma­
tous biliary cirrhosis* Analysis of the Cohn 
fractions in a density gradient confirmed that the 
lipoproteins in fractions IV + V, and VI was con­
centrated into a density range close to that of beta 
lipoprotein./
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lipoprotein. In the analytical ultracentrifuge 
13 species predominated in fraction IV + V, and 
25, 29 and I6 in fraction VI while fraction
I + III was almost entirely 8^ 3.
Although the lipoproteins in the Cohn fractions, 
which normally contain alpha lipoprotein, behaved as 
beta lipoprotein in many respects, they failed to 
react with an anti-beta lipoprotein antiserum. Russ 
et al (1956) suggested that either the abnormal lipo­
protein was antigenically dissimilar or that the 
antigenic site was blocked by the lipid (the ratio of 
peptide :lipid was reduced in all the fractions isol­
ated). The anti-beta lipoprotein antiserum reacted 
normally with fraction I and III,
An antiserum prepared against aged high density 
lipoprotein was subsequently found by DeLalla et al 
(1957) to react with lipoprotein d < I.O63 from the 
serum of the patient originally studied by Russ et 
al (1956); this antiserum did not react with normal 
low density lipoprotein. No conclusions were draim 
by/
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by DeLalla et al (l957) on the signficance of 
their finding.
The occurrence of alpha lipoprotein of 
abnormal density in obstructive jaundice was 
suggested by Etienne et al (1966)* Although 
they found alpha lipoprotein to be absent on 
paper electrophoresis, they observed an alpha 
lipoprotein precipitin arc of reduced mobility 
using immunoelectrophoresis. The abnormal frac­
tion, as indicated by immunoelectrophoresis, was 
found within the density range I.O63 - 1*020 
together with the beta lipoproteins.
A different lipoprotein abnormality in the 
serum of patients with obstructive jaundice was 
subsequently described by Switzer (1967). He 
found most of the lipid in such patients to be at 
d 1.019 - 1.063 and to show no reactivity with a 
potent anti-beta lipoprotein antiserum. Purified 
preparations of this material did not react with 
antisera to beta lipoprotein, alpha lipoprotein or 
normal/
- 36 -
normal human serum,, It was rich in phospholipid 
and free cholesterol and low in protein. An 
antisera prepared against the abnormal fraction 
cross-reacted m t h  normal d < 1*006 lipoproteins©
He suggested that this fraction represented an 
"obstructive jaundice lipoprotein" or "OLP" most 
closely resembling the VLDL fraction©
Wliile this thesis was being prepared, Seidel 
et al (1969) claimed to have isolated 3 immuno- 
chemically distinct lipoproteins LF-A, LP-B and 
LP-X from the LDL fraction (d 1©006 - 1,063) of the 
plasma of patients with biliary obstruction, LP—A 
was defined as a lipoprotein characterised by 
presence of apolipoprotein A, and LP-B as lipoprotein 
characterised by presence of apolipoprotein B*
LP-X had a characteristically high content of free 
cholesterol and phospholipid, resembled in these 
respects the abnormal lipoproteins described in 
Cohn fraction VI by Russ et al (1956) and the OLP 
of Switzer (1967) and was primarily responsible for 
the/
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the unusual protein and lipid content of the LDL 
fraction© It was speculated that LP—X might he 
intestinal lipoprotein, similar to the G lipo­
protein described by Gustafson et al (1966), 
normally rapidly ©atabolised in the liver and so 
largely undetectable in normal plasma, but 
accumulating in the plasma when liver derangement 
led to a decrease in its degradation rate© Screen­
ing tests in patients with various forms of jaundice 
showed LP-X to be limited to those subjects with an 
obstructive lesion*
SECTION II
INVESTIGATION
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OBJECT OF INVESTIGATION
Since the various operational methods of 
defining the plasma lipoproteins fail to provide 
a totally consistent account of the alterations in 
the lipoprotein in subjects with various forms of 
obstructive jaundice, the present study was con­
ceived* Its aim was to reinvestigate the lipid 
and lipoprotein changes in such subjects, especially 
by exploiting the immunochemical specificity of alpha 
and beta lipoproteins to permit their definitive 
identification.
Special objects of the study were —
(a) the resolution of the conflicting evidence
on the changes in alpha lipoprotein;
(b) whether a true hyperbetalipoproteinaemia
occurs;
(c) the quantitative factors determining the
altered behaviour of the lipoproteins;
(d) whether subjects with biliary cirrhosis
differ/
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differ from those with other forms 
of obstructive jaundice in their 
lipid and lipoprotein abnormalities,
CHAPTER 1 
SUBJECTS AND METHODS
mm 40 —
SUBJECTS
TSfeiity-one patients with jaundice due to 
extra- or intra-hepatic cholestasis, or biliary 
cirrhosis were studied© Eighteen were under the 
care of various physicians (see Adenowledgements) 
who provided the plasma samples and the relevant 
clinical and laboratory findings* The other 3 
patients attended the Clinical Center of the 
National Institutes of Health* Table 3ol sets 
out the diagnosis given for each patient with the 
age and sex* The patients* serum total bilirubin 
and alkaline phosphatase levels at the time of 
sampling are given in Table 3o2 and were elevated 
in every case; the raised enzyme levels fell into 
the range associated with obstructive jaundice*
In all but 1 case, the cause of the jaundice had 
been established; the exception was subject no*
9 in whom the diagnosis of intra-hepatic cholestasis 
was based on the biochemical features and the 
absence of extra-hepatic biliary obstruction as 
assessed/
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assessed during surgery* Subjects no# 14, l6 and 
20 were serially sampled during and after the 
jaundiced phase#
Blood samples were also obtained from 3 male 
and 2 female apparently healthy subjects whose ages 
ranged from 2? - 35 years# The main purpose of 
these control samples was to monitor the complete­
ness of the ultracentrifugal separations rather 
than to provide quantitative control data# The 
samples were handled similarly to those of the 
jaundiced subjects and one was Included with each 
batch of patient samples© In contrast to the 
findings which are to be described in some of the 
patients, the LDL fraction of the control subjects 
was found to contain beta lipoprotein only# When 
limited or no data was available for the normal 
values of a given parameter, the control data was 
especially used for comparison#
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METHODS
Blood was obtained from each subject in the 
morning after an overnight fast* It was anticoagu­
lated with Ool^ EDTA to a concentration of 1 mg/ml© 
The plasma was obtained following centrifugation at 
4^ and stored at this temperature.
Aliquots of the plasma were taken for deter­
mination of total cholesterol, high density lipo­
protein cholesterol, triglyceride and phospholipid 
levels and for the relative amounts of free to 
ester cholesterol* Lipoprotein electrophoresis on 
paper and immunoelectrophoretic analysis in agar 
and agarose were also performed on the plasma.
The various methods employed are described below.
Isolation of Lipoprotein Fractions 
Preparative ultracentrifugation: Plasma lipoprotein
fractions were separated using the preparative ultra­
centrifuge by the method of Havel et al (l955)o 
5 ml of plasma was added to each of 2 cellulose 
nitrate x 2ÿ*) tubes* The plasma was layered 
with/
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with 1.5 ml of 0.01 M EDTA - 0.13 M Na Cl solution 
and ultracentrifuged at 10° in the 40.3 rotor of a 
Spinco Model L preparative ultracentrifuge at 
39,000 rpm (ca. 100,000 g) for at least l6 hours.
The tubes were then sliced 2©1 cm below the lower 
rim of their caps. The top layer (d < 1.006 frac­
tion) from each tube was combined and the volume 
made up to 5 ml with EDTA-a aline. The bottom 
layers (d > 1.006 fraction) from the 2 tubes were 
also combined and restored to a volume of 10 ml 
using EDTA-saline. Aliquots of both fractions 
were taken for cholesterol determination, paper 
electrophoresis and iramunoelectrophoresis. Of the 
balance of the d > 1.006 fractions 5 ml was allocated 
to 1 cellulose nitrate tube and 4 ml to another.
To the tube containing 5 ml was added 1 ml of a 
mixed salt solution of d 1.35 (l53 G Na Cl +
354 G lŒr/b) producing a mixture of d I.O63 which 
was layered with a solution of d I.O63 (10 ml EDTA- 
saline of d 1.006 + 2 ml Na Cl + lŒr solution of
a 1.35)/
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d 1.35).
To the tuhe containing 4 ml was added 1 ml of 
EDTA-saline and thereafter it was brought up to 
d I0O63 as described for the first tube* They were 
then ultracentrifuged under similar conditions as 
the whole plasma. The tubes were sliced; the 
bottom fractions (d > I0O63) from each tube were 
combined and made up to a volume of 10 ml with 
EDTA-saline* Aliquots were taken for lipid deter­
minations and for dialysis prior to electrophoresis* 
The top fraction (d 1*006 - 1*063) from each tube 
was recovered and transferred to a further tube, which 
was filled vrith the Na Cl KBr solution of d I.O63 
and ultracentrifuged a second time* The tube was 
sliced and the bottom fraction discarded* The top 
fraction from each tube was kept separate and brought 
to a volume of 5 ml*
The LDL fraction which had been obtained from 
the 5 ml of the original d > I.OO6 fraction, so that 
the lipoprotein was at plasma concentration, was 
used/
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used for quantification of lipid and protein 
concentrations.
The LDL fraction which had been obtained 
from the 4 ml of the original d > 1.006 fraction 
was dialysed at 4° against at least 100 volumes of 
0.15 M Na Cl containing 0,01 M EDTA, The dialysis 
fluid was changed* 3 times during the l6 hour 
period. This fraction was subsequently used for 
the various iimnunochemical and electrophoretic 
procedures.
Cholesterol Determination: Plasma cholesterol
levels were determined following direct extraction 
of the plasma lipids by isopropanol (l vol plasma:
20 vol isopropanol). The cholesterol levels in the 
LDL or HDL fractions were determined following 
extraction of the lipids by 25 vol of chloroform; 
methanol (2 vol;l vol) to which was added 5 vol 
acidified water (concentrated HgSO^rHgO 2000 vol:
1 vol). The chloroform phase was recovered, appro­
priate aliquots were taken to dryness, and the 
lipids/
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lipids redissolved in 2 ml isopropanol for the 
cholesterol determination* High density lipo­
protein cholesterol levels in the plasma were 
determined in the supernate obtained following 
precipitation of all lipoproteins other than HDL 
by the addition of 0,15 ml 0*1 M manganese chlor­
ide and 6 mg of sodium heparin (Burstein and 
Samaille, I960) to 3 ml of plasma. The supernate 
was extracted with chloroform:methanol as described 
above, and the cholesterol determination was per­
formed in an isopropanol solution.
Cholesterol levels were determined using Auto­
analyser method N-24b in which an anhydrous colour 
reagent containing ferric chloride in a mixture of 
acetic and sulphuric acids reacts with cholesterol 
and develops a colour which is read at 55C mu. 
Triglyceride Determination: Triglyceride levels
were determined by the semi-automated fluorometric 
procedure of Kessler and Lederer (1965) in which 
manually prepared isopropanol extracts of the plasma 
or/
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or the LDL fraction were treated with a zeolite 
mixture (200 G zeolite, 20 G Lloyd Reagent, 10 G 
CuSOj^  10 HgO, 20 G Ca (OH)^) to remove phospho­
lipids, glucose, hiliruhin and other chromogens*
The automated system saponifies the triglyceride 
with KOH to glycerol, which is then oxidised to 
formaldehyde with periodic acid* The formaldehyde 
is condensed with diacetylacetone and ammonia 
(Hantzsch condensation reaction) yielding the 
fluorescent product 3, 5 " diacetyl - 1, 4 dihydro- 
lutidine* A blank determination on the isopropanol 
extract of each plasma was carried out by omitting 
the saponification step* The result obtained from 
this sample was used to correct for possible con­
tamination from bilirubin which had not been removed 
from the icteric plasma by the zeolite mixture* 
Phospholipid Determination; Phospholipid levels 
in the plasma, LDL and HDL fractions were determined 
by a modification of the method of Bartlett (l959)o 
Prior extraction of the plasma or the lipoproteins 
was/
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was carried out with chloroform:methanol in the 
usual manner. Aliquots of the chloroform phases 
were taken to dryness and digested with 0©1 ml 
concentrated H^SO^ in a tube heater at 180° for 
one hour* The samples were cooled slightly and 
4 drops of 30^ H^Og were added. The samples were 
reheated for 30 minutes until they were clear; 
if necessary additional H^O^ was added and the 
step repeated. To each tube was then added 2,3 
ml 0m22fo ammonium molybdate and 0.1 ml amino- 
naphthol sulfonic acid solution (0,25 G 1 - amino - 
2 naphthol - 4 - sulfonic acid was added to 100 ml 
freshly prepared 15^ sodium bisulfite solution to 
which was added 0*5 G sodium sulfite. It was stood 
overnight at 4°, filtered and stored at 4° in a 
dark bottle. It was prepared weekly,)* Following 
thorough mixing, the tubes were heated in boiling 
water for 7 minutes and cooled to room temperature. 
The optical density was then read at 830 mu, A 
factor of 23 was used to convert the results for the 
lipid/
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lipid phosphorus concentration into phospholipid 
concentration.
Protein Determination: The protein concentration
of the LDL fraction was measured by the method of 
Lowry et al (l95l)î to 0,4 ml of the LDL fraction 
was added 2,0 ml of an alkaline copper solution 
(50 ml 2^ NagCO^ in 0.10 N Na OH + 1 ml 0.5^
CuSO. .SHgO in Vfo sodium or potassium tartrate).
After 10 minutes 0,2 ml of Folin-Ciocalteau phenol 
reagent was added, and after 30 minutes the optical 
density was read in a Coleman colorimeter at 660 mu,
A bovine albumen standard was used.
Thin Layer Chromatography: The relative amounts
of free cholesterol to cholesterol ester in chloro­
form extracts of the plasma or of lipoprotein bands 
from paper electrophoretic strips was determined 
using thin layer chromatography (Stahl), Commer­
cially available pre-coated 20 cm x 20 cm silica gel 
plates were used (Brinkman), The solvent system 
used was petroleum ether ; diethyl ether : glacial acetic 
acid/
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acid (90:10:1), After development of the plates 
the free and ester cholesterol spots were located 
using iodine vapour. They were scraped off the 
plate and the lipid was extracted in chloroform, 
taken to dryness and redissolved in isopropanol 
for cholesterol determinations*
The same solvent system was employed for 
separation of non-polar lipids before and after 
absorption of the LDL fraction with various anti­
sera as described below; for polar lipids the 
solvent system used was chloroform;methanol:water 
(195Î75!12)0 Both the non-polar and polar plates 
were sprayed with a mixture of glacial acetic acid: 
concentrated sulphuric acid: anisaldehyde (97:2:l),
dried in an oven at 110°for 10 minutes, immediately 
inspected with the naked eye and photographed.
The amounts of lecithin, sphingomyelin and 
lysolecithin expressed as a percentage of the total 
lipid phosphorus recovered from each plate was 
determined/
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determined in eluates of paper electrophoretic 
strips using two-dimensional thin-layer chromato­
graphy, The solvent systems used were chloroform: 
methanol: concentrated ammonium hydroxide;water 
(l80:105:7«5:7,5) for the first dimension, and 
chloroform:methanol:concentrated ammonium hydroxide: 
water (l20:l60:5:5) for the second dimension. The 
spots were located using iodine vapour, scraped off 
the plate, and their lipid extracted with chloro­
form* The chloroform was evaporated and the lipid 
was redissolved in a given volume of chloroform and 
its phospholipid content determined*
Immunochemi stry 
Immunoelectrophoresis : Immunoelectrophoretic
analysis was carried out on the plasma or lipoprotein 
fractions, following the method of Grahar and Williams 
(1955) adapted for microscope slides hy Scheidegger 
(1955). Commercially pre-cleaned standard slides 
were first coated with a thin film of 2$ agarose or 
1^ difco special nohle agar in 0*05 M harhital buffer 
(pH 8.2)/
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(pH 8o2), Two ml of buffered agarose or agar was 
then applied uniformly to each slide and allowed to 
gel# The plates were used shortly after preparation. 
Appropriate wells and troughs were cut out, and 2-3 
ul of the plasma or the lipoprotein fractions was 
then put in a well and electrophoresed in 0,05 M 
barbital buffer (pH 8,2) at constant current (58 ma 
for agar; 44 ma for agarose) for exactly 40 minutes. 
The relevant antisera were added to the troughs and 
the slides were stored at room temperature for 24 
hours in a high humidity chamber. They were then 
inspected for immunoprecipitin arcs, and photographed. 
The slides were washed overnight in saline and 
distilled water, dried and stained for lipid by 
immersion in a saturated solution of Oil red 0 in 
60/^  ethanol at 40° for 12 hours.
Immunodiffusion; Immunodiffusion studies were 
carried out in Ouchterlony (l958) plates prepared 
with vfo difco special noble agar in saline. They 
were/
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were developed at 4° and were inspected for precipitin 
lines and photographed at 24, 48 and 72 hours. All 
immunoprecipitin bands or lines held to represent 
lipoprotein were subsequently shoivn to stain for 
lipid with Oil red 0.
Antisera: A variety of antisera were used. All but
2 of them had been previously raised in the Laboratory 
of Molecular Diseases against various antigens and 
were made available to the author. Details of the 
procedures used for their production are given by 
Levy and Fredrickson (1965). The species in which 
the antisera had been raised and the kno’^ra reactivity 
of the antisera are set out in Table 3*3, Tvfo of 
the antisera (36O, Hyland anti-beta) had anti-beta 
lipoprotein reactivity only. All but one (ZAZ2) of 
the remaining anti sera were knoivn to react with alpha 
and beta lipoprotein; some of these also had reactivity 
against other plasma proteins. The anti-beta lipo­
protein reactivity of antisera R1-R5 varied and was 
sometimes weak. Antiserum ZAZ2, which had been 
prepared/
-  54 -
prepared in rabbits using plasma from an 
abetalipoproteinaemic subject as the antigen, 
had anti-alpha lipoprotein but no anti-beta 
lipoprotein reactivity. It also reacted with 
pre-beta lipoprotein.
Gamma Globulin Preparation: Gamma globulin
preparations of antisera 36O and 124A were prepared 
as described by Kekwick (l940). To each 100 ml of 
serum was added 18 G anhydrous Na^SO^. The solu­
tion was warmed to 30° for 2 hours. It was then 
centrifuged at 25^ providing a fairly clear super­
nate which was discarded. 10 ml of water was added 
and (observed voltuiie -10) ml was taken as the vol­
ume of the precipitate. This solution was made 
up to 40 ml and Na^SO^ added to a concentration of 
12^. It was warmed, stood and centrifuged as before, 
giving a clear supernate. To the precipitate was 
again added 10 ml of water to determine its volume, 
and the mixture was taken to a volume of 20 ml and 
a 12^ Na^SO^ solution was again produced. After 
warming and standing, a quite clear supernate was 
obtained/
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obtained. The precipitate, which consisted of 
gamma globulin, was taken up in a small volume of 
0*15 M saline and dialysed against 0.15 M saline* 
Lipoprotein Paper Electrophoresis: Electro­
phoretic analysis of plasma and of the ultracentri­
fugal fractions was performed on Wliatman No. 1 
paper (thickness 3 mm) by the Durrum hang-strip 
method in Beclonan model R cells with barbital 
buffer (ionic strength 0.1, pH 8.6) containing 
0.001 M EDTA and Vfo albumen according to the method 
of Lees and Hatch (1963) except that bovine rather 
than human albumen was used* For electrophoresis 
of plasma or of the fractions d > 1.006, d I.OO6 - 
1*063 and d > 1*063, 20 )il samples were applied to 
each strip; for the fraction d < 1.006, 40 jil 
samples were applied except when indicated in the 
text. The samples were run for I6 hours at con­
stant voltage (120 v) producing a current of 0.75 -
1.0 ma per strip. The strips were dried for 20 
minutes at 95^, immersed in a supersaturated solution 
of/
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of Oil red 0 for 4 - 6  hours at 40°, rinsed and 
then dried.
The Oil red 0 was prepared hy refluxing, in 
a round-bottomed flask 1.5 L of ethyl alcohol,
1,0 L of water, and 1 G of Oil red 0, After the 
mixture had boiled it was allowed to cool and was 
then stored at 37 - 40° (Fredrickson et al, I967).
In specified instances samples of LDL 
fractions were run in albumen-free buffer and 
corresponding strips stained for lipid with Oil 
red 0 and protein with bromophenol blue.
The strips to be stained for protein were 
immersed, for 2 hours, in 0.01^ bromophenol blue 
in a 5fo zinc sulphate and acetic acid solution. 
They were then washed twice for 3 - 5 minutes in 
a 2$ acetic acid solution, then for 5 minutes in 
a sodium acetate-acetic acid solution and dried. 
Partial Delipidation of LDL Fraction: A slight
modification of the method of Avigan (l957) was 
employed/
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employed in which fresh (peroxide-free) diethyl 
ether was equilibrated for 20 mins in ice with an 
equal volume of diluted NH^OH (l drop NPI^ OH to 
100 ml distilled H^O)* 0.2 ml of the LDL frac­
tion was shaken with 50 ml of the ether for 4 - 6 
hrs at 4°. The ether phase was removed by 
suction, the remaining solvent being evaporated 
with a nitrogen stream. The delipidated lipo­
protein fraction in the remaining aqueous phase 
was used without delay for the immunochemical 
studies.
Details of other procedures are provided in 
certain subsequent chapters.
CHAPTER 4
IMMUNOCHEMICAL IDENTIFICATION OF ALPHA 
LIPOPROTEIN OF ABNORMALLY LOW DENSITY 
AND ALTERED ELECTROPHORETIC MOBILITY
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Plasma lipoproteins show differing mobility 
during immunoelectrophoresis in agar or agarose 
gels (Pigo 4ol)o In 2^ agar, beta lipoprotein 
hardly leaves the origin, and pre-beta lipoprotein 
behaves similarly so that it cannot be distinguish­
ed (Levy et al, 1966)* In Vfo agarose, beta lipo­
protein migrates with the mobility of a beta- 
globulin (Burstein and Fine, 1964, Levy et al,
1966) and pre-beta lipoprotein can be identified 
since it migrates between alpha and beta lipoprotein 
with alpha^-globulin mobility (Levy et al, 1966)0 
Beta lipoprotein tends to react with agar and agar­
ose gels, especially the forraero In the present 
study agar gel (Figo 4*2) was mainly used for 
immunoelectrophoretic analysis since, as indicated 
below, it proved to be the most satisfactory medium 
for demonstrating the abnormal precipitin arc found 
in some of the jaundiced subjects©
When plasma from each of the 21 icteric sub­
jects was immunoelectrophoresed in 2^ agar gel,
12/
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12 showed alpha and beta lipoprotein precipitin 
arcs only, the intensity of the former being 
diminished in several cases. An additional pre­
cipitin arc was present in the plasma of the other 
9 subjects; this was a short, well-defined arc 
just peripheral to the beta lipoprotein arc and 
which had migrated slightly towards the cathode 
(Fig. 4.3). A dense material which had reacted 
with the agar gel, just internal to the new 
precipitin arc (Fig. 4.4a), was also often seen.
The plasmas containing the additional arc were 
examined with a variety of anti-lipoprotein anti­
sera. The new arc was observed with antisera 
with combined anti-alpha and anti-beta lipoprotein 
reactivity but not with monospecific anti-beta 
lipoprotein antisera; for example, in subject 
no. 14 it was produced with antisera Rl, R2 and R5, 
124A, alpha LpT^ and 51* It was not produced by 
either of the two monospecific anti-beta lipoprotein 
antisera, 360 and Hyland anti-beta (Figs. 4.4a and 
h.hh/
— 60 —
4.4b).
The various ultracentrifugal fractions were 
similarly examined for the new precipitin arc.
It was not observed in the VLDL fraction nor, in 
particular, in the HDL fraction (Fig, 4.5) in which 
a normal alpha lipoprotein arc was visible. It 
was present in the d > 1.006 fraction (Fig. 4,6) 
and was found to reside in the LDL fraction (Fig.
4.7).
Immunoelectrophoresis of the plasma and the 
LDL fraction in ifo agarose gel was also performed.
It proved a less satisfactory medium for demon­
strating the new precipitin arc which displayed an 
electrophoretic mobility similar to that of beta 
lipoprotein. Nevertheless, in some instances, an 
additional arc was clearly evident (Figs, 4.8 and
4.9).
The LDL fraction from the plasma of each of 
the subjects with the new precipitin arc was further 
examined by immunodiffusion in Ouchterlony plates* 
Such/
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Such a procedure, in normal subjects, when 
appropriate antisera are used, results in the 
production of a single beta lipoprotein precipitin 
line and this was observed for 10 of the 12 sub­
jects who had not sho™ the new arc on immuno­
electrophoresis (Figo 4ol0)* In the 9 subjects 
with the new arc, 2 lines were observed when the 
LDL fraction was diffused against anti-alpha and 
anti-beta lipoprotein antisera; a line giving a 
reaction of identity with the beta lipoprotein 
precipitin line either from a normal subject or 
those jaundiced subjects without the additional 
line, and a new precipitin line peripheral to the 
first line in relation to the centre well (Figo
4.10). A single precipitin line showing identity 
with the normal beta lipoprotein line was found 
when a monovalent anti-beta lipoprotein antiserum 
was diffused against the LDL fraction (Figo 4.10)o 
The LDL fraction was examined with a variety 
of antiserao As was the case for the immuno­
electrophoretic/
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electrophoretic findings, the new precipitin line 
was produced with several anti-alpha and anti­
beta lipoprotein antisera, these being, for example, 
in subjects no. 14 and 15, 124A, RGA, Rl, R5, alpha 
LpT^, alpha LpT^, AHS, and 79; the monovalent anti­
beta lipoprotein antisera 360 and Hyland anti-beta 
each saw a single line only.
The abnormal immunoelectrophoretic and inmiuno- 
diffusional findings just described were not obtained 
f^ith all the antisera with anti-alpha lipoprotein 
reactivity.
It was possible, in several subjects, to study 
their plasma and LDL fractions during and after 
their jaundiced phase* In each instance the abnormal 
precipitin arc, which was present during the jaund­
iced phase, disappeared with the relief of the 
obstruction. For example, subject no. l6 was studied 
on 4 occasions (Fig. 4.1l). On the first 3 (Mar. 7th, 
11th and 20th) his plasma cholesterol was 526, 596 and 
566 mg/100 ml respectively and his plasma phospholipid 
1,155, 1,044 and 1,128 mg/lOO ml. As Fig, 4,11 shows, 
the abnormal precipitin arc was present in each plasma, 
together/
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together with normal beta lipoprotein and faint 
alpha lipoprotein precipitin arcs. By Mar. 29th, 
when the plasma cholesterol had fallen to 330 mg/
100 ml and the phospholipid to 383 mg/lOO ml, the 
abnormal arc was no longer present, there being 
only the normal beta and alpha lipoprotein arcs. 
Similarly the disappearance of the abnormal pre­
cipitin arc following relief of the jaundice was 
observed in the d > 1,006 fraction (Fig, 4,6) and 
in the LDL fraction itself (Fig. 4.9),
Immunodiffusion studies in Ouchterlony plates 
gave similar results* In Fig. 4.12 as described 
above, the LDL fraction of subject no, 14 (Dec, 14th), 
when she was jaundiced with a plasma cholesterol of 
640 mg/lOO ml and a plasma phospholipid of 1,062 mg/ 
100 ml, showed the additional precipitin line with 
several antisera with anti-alpha and anti-beta 
lipoprotein reactivity* This line was no longer 
evident in the LDL fraction from the sample of 
Feb, 2nd when the jaundice had been relieved, the 
plasma cholesterol had fallen to 288 m^lOO ml and 
the plasma phospholipid to 371 mg/lOO ml. The 
fraction/
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fraction now only showed the expected single beta 
lipoprotein precipitin line. Similar findings are 
seen in Fig. 4,10.
The additional precipitin line observed in 
the immunodiffusion studies was further character­
ised by examination of the LDL fractions before 
and after absorption with several antisera. 0*1 
ml of the LDL fraction was reacted for 72 hrs at 
4^ with 0,2 ml or 0.3 ml of antiserum 124A (anti­
alpha and anti-beta lipoprotein) or the monovalent 
anti-beta lipoprotein antisera 360 or Hyland anti- 
beta* The supernates were recovered and immuno- 
diffused against a variety of antisera* In 
addition two- or three-fold dilutions of the LDL 
fractions were similarly treated* In Fig* 4,13 
typical findings are shown. The saline-diluted 
LDL fractions still produced two precipitin lines 
following diffusion against antiserum R5 with 
anti-alpha and anti-beta lipoprotein reactivity. 
The supernates from the LDL fraction which had 
been/
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been reacted with the monovalent anti-beta lipo­
protein antiserum showed removal of the inner 
precipitin line, which had previously been shoim 
to give a reaction of identity with normal beta 
lipoprotein (Fig, 4*11); the additional precipitin 
line had not been removed by the anti-beta lipo­
protein antiserum. The supernates from the
fraction reacted with O .3 ml of the anti-alpha and 
anti-beta lipoprotein antiserum showed removal of 
the beta lipoprotein and the new precipitin lines. 
The LDL fraction, containing the abnormal 
precipitin arc or line, was able to absorb the 
anti-alpha lipoprotein reactivity from a poly­
valent antiserum* The 4 LDL fractions of the plasma 
of subject no, I6, obtained at various stages during 
and after his jaundice, were each reacted with an 
equal volume of polyvalent antiserum 81 with anti­
alpha lipoprotein reactivity for 72 hrs at 4^,
The supernates were obtained and immunodiffused 
against HDL prepared from a normal subject* The 
antiserum/
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antiserum itself and a saline dilution (l:l vol:vol) 
of the antisera were similarly studied. In Fig, 
4,14 it is seen that the undiluted and diluted 
antiserum reacted with the normal HDL preparation 
to produce an alpha lipoprotein precipitin line*
The supernates from the antisera reacted with the 
LDL fractions of Mar* 3rd and ?th no longer showed 
this anti-alpha lipoprotein reactivity and only a 
faint line is evident relating to the preparation 
of Mar, 11th, On the other hand the supernate of 
the antiserum treated with the LDL fraction of 
plasma taken on Mar, 29th when the jaundice was no 
longer present, when the plasma lipids had fallen 
substantially and the abnormal precipitin lines 
were absent, preserved its anti-alpha lipoprotein 
reactivity*
As subsequently discussed, it is thought that 
the additional precipitin arc or line observed in 
these various studies is a product of an over- 
lipidated alpha lipoprotein of abnormally low 
density/
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density* Accordingly the effect of partial 
delipidation of the LDL fraction was studied.
The LDL fractions were partially delipidated 
using cold ether as described in Chapter 3 and 
the ether was removed. The delipidated fractions 
were promptly examined by immunodiffusion; the 
abnormal line, peripheral to the beta lipoprotein 
precipitin line, was found to have disappeared and 
a new line was seen between the beta lipoprotein 
line and the central well. This line gave a reac­
tion of partial identity with a heptane-delipidated 
HDL preparation from a normal subject (Fig. 4.13)# 
Ether delipidation of the LDL fraction was 
also found, on immunoelectrophoretic analysis, to 
remove the abnormal precipitin arc and to produce 
a lipoprotein precipitin arc with a mobility 
approximately equal to normal alpha lipoprotein 
(Fig, 4*l6),
The results of these various immunochemical 
investigations are summarised and discussed in 
Chapter 6.
CHAPTER
PAPER ELECTROPHORETIC STUDIES; 
DEMONSTRATION OF A LOW DENSITY LIPOPROTEIN 
WITH UNUSUAL STAINING PROPERTIES
—  6s —
The immunochemical studies described in 
Chapter 4 show that, in certain subjects with 
obstructive jaundice or biliary cirrhosis, there 
occurs an alpha lipoprotein form of abnormally 
low density and changed electrophoretic mobility 
in agar and agarose gels, and with an altered 
rate of diffusion in agar gel in an Ouchterlony 
plate.
This chapter mainly describes the identi­
fication, by paper electrophoresis, of an 
additional lipoprotein band, which showed 
unusual staining properties, within the LDL 
fraction of these subjects.
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Paper Electrophoresis of Plasma; The fasting 
plasma of each of the 9 subjects with the 
additional lipoprotein within the LDL fraction 
showed, on paper electrophoresis, a normal or 
slightly intense beta lipoprotein band (Fig* 5*l)* 
In 5 of the subjects (nos. 13, l6, 18, 19 and 2l) 
this band tended to be widened and indistinct 
(Figo 5*l), resembling the ’’broad beta” band of 
Type III hyperlipoproteinaemia (Fredrickson et al,
1967)* Since the presence of additional lipo­
protein in the LDL fraction of these subjects 
prevented the quantitation of the beta lipoprotein 
within this fraction, a comparison of the intensity 
of the beta lipoprotein bands with beta lipoprotein 
levels could not be made*
A distinct pre-beta lipoprotein band was 
absent from the plasma of all but 1 (no© 14) of the 
subjects (Fig* 3ol), although they each had a 
triglyceride level which exceeded that in which a 
pre-beta/
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pre-beta lipoprotein band usually occurs (80 mg/
100 ml)* For example, subject no. l6 had a tri­
glyceride level of 600 mg/lOO ml in his plasma 
sample of Mar* 7th but no pre-beta band.
The alpha lipoprotein band was reduced in 
intensity or absent in the electropherogram of 
the plasma (Fig* 5ol) of every subject except 1 
(no. 17) whose band appeared normal* This is in 
keeping with the low alpha lipoprotein cholesterol 
and phospholipid levels of the subjects as 
described in Chapter 10*
The typical electropherogram of the plasma of 
these subjects therefore consisted of a beta lipo­
protein band of normal or slightly increased 
intensity, sometimes broadened and indistinct, with 
a reduced or absent alpha lipoprotein band and an 
absent pre-beta lipoprotein band. Chylomicrons 
were not seen,
VLDL Fraction: A lipoprotein band of beta
mobility was present in the VLDL fraction of 4 of 
the/
— 71 —
the 9 subjects and "trail” was frequently present 
(Figo 3.2)0 The significance of this "floating" 
beta lipoprotein which was also observed for other 
subjects, is discussed in Chapter 12*
HDL Fraction; An alpha lipoprotein band was 
absent or only faintly present in the HDL fraction 
of all but 1 subject (noo 17) (Fig, 3.3) compat­
ible with the appearances produced by their 
plasma*
LDL Fraction; The LDL fraction of all but 1 
(noo 13) of the 9 subjects showed, with the Oil 
red 0 stain, a single band of beta mobility 
(Figo 3.4)o The beta lipoprotein bands were 
quite sharp and of normal width even in the 5 
subjects whose plasma had sho^m a "broad” beta 
band, suggesting that this abnormal plasma band 
was due to lipoproteins not contained within the 
LDL fraction*
The LDL fractions were also electrophoresed 
in barbital buffer to which albumen had not 
been/
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been added to permit the use of a protein stain© 
Corresponding strips were stained for protein 
with bromophenol blue, and for lipid with Oil red 
0, In all subjects except no© 15 there was a 
protein band corresponding to the beta lipoprotein 
band stained by Oil red 0, and an abnormal band 
which had migrated to a point between the beta 
band and the origin (Figs. 5.5a and 5#5h). 
Occasionally this additional band was faintly 
visualised with Oil red 0 (Figs© 5,5a and 5,5h).
The presence of the abnormal band appeared 
to be related to the coincident jaundice since 
it was not present in those samples taken from 
subjects no© 14 and l6 after the jaundice had 
been relieved. For example Figs. 5*5a and 5*5h 
show the appearances in the LDL fraction of 
subject l6; 2 bands are present in each of the
3 fractions obtained when he was Icteric but only 
a beta band is present in the 4th sample obtained 
when his jaundice had disappeared.
Subject/
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Subject no. 15 showed 2 bands with either 
stain; a beta lipoprotein band and a cathodal 
migrating lipoprotein band (Fig. 5#6)©
Although the abnormal band, which was 
designated the "slow” band, in the LDL fraction 
of the Group III subjects other than no. 15, did 
not usually stain for lipid with Oil red 0, it 
was subsequently shoim to contain lipid. For 
example, the LDL fraction of subject no. l6 
(Mar. 11th) was electrophoresed on 6 paper strips 
(40 jal/strip) simultaneously in a single cell.
The 2 outer strips were stained for protein with 
bromophenol blue to locate the slow and beta 
lipoprotein bands. Using these strips as guide­
lines the portions of the remaining 4 strips 
corresponding to each of the bands were removed, 
cut into small pieces and pooled. The pooled 
material from each band was extracted with 10 ml 
chloroform;methanol (2:1 voltvol) for l6 hrs, the 
chloroform phase was recovered after the addition 
of/
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of 2 ml of acidified water, and was taken to dry­
ness. The material so obtained was redissolved 
in a small volume of chloroform and chromatographed 
in thin-layer silica gel G plates in one dimension 
using the non-polar and polar solvent systems 
described in Chapter 3# The spots were stained 
with anisaldehyde© Non-polar and polar lipids 
were found in the samples derived from the slow 
band. The non-polar lipid from this band consisted 
mainly of free cholesterol, with faint traces of 
cholesterol ester and triglyceride (Fig. 5#7)«
The most prominent polar lipid was lecithin 
although a fainter sphingomyelin spot was also 
seen (Fig, 5*8), The beta lipoprotein band also 
produced non-polar spots corresponding to free 
and ester cholesterol, and triglyceride (Fig, 5*9) 
and polar spots corresponding to lecithin and 
sphingomyelin (Fig. 5®8) although the latter spot 
was less prominent than the corresponding spot 
from the slow band© Preliminary measurements 
of/
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of the relative amounts of the various lipids 
present in the slower and heta bands of 2 
subjects were carried out© The ratio of free 
cholesterol: cholesterol ester in each of the 2 
bands was determined; six paper strips were 
electrophoresed as described above, the slow 
and beta bands located, and the lipid extracted 
with chloroform-methanol and taken into the 
chloroform phase. Half of this phase was 
ultimately chromatographed using a non-polar 
solvent system. The free and ester cholesterol 
spots were located with iodine vapour* Each 
spot was scraped off the plate and extracted with 
50 ml chloroform* The chloroform was taken to 
dryness and the lipid redissolved in isopropanol 
and cholesterol concentration was determined* The 
results of this analysis which were carried out for 
subject no, l6 (Mar* 7th and 11th) and subject no* 
18, are shoivn in Table 5.1.
The percentage of the total cholesterol 
present/
- 76 -
present as free cholesterol in each of the 3 slow 
hands was high, ranging from 79 - 87^# The beta 
band of subject no, l6, on each occasion showed 
a smaller but still considerable amount of its 
total cholesterol to be in the free form namely 
81^ (Mar, 7th) and 70^ (Mar, 11th); that of 
subject no, l6 showed only 36^ to be free. Of 
the total cholesterol in the LDL fraction of 
subject no. I6 (samples of Mar, 7th and Mar, 11th)
86^ and 82^ respectively was free cholesterol 
(Table 5«l). This is very close to the correspond­
ing figures for their total plasma cholesterol, of 
which 85^ and 88^ was free (Table 10.4),
The percentage of the total LDL cholesterol 
which was in the slow band ranged from 59 - 77^ 
in the 3 analysis for these 2 subjects (Table 5#l).
The levels of the individual phospholipids in 
the slow and beta lipoprotein bands of subject no, I6 
were also measured; the lipids were eluted from 
the paper strips and developed, in 2 dimensions, 
ty/
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by thin-layer chromatography in silica gel G as 
described in Chapter 3*
Lecithin (Table 3*2) was the predominant lipid 
in the slow and beta bands constituting 74.1^ and 
79*3^ respectively of the total phospholipid in 
each band. The slow band contained rather more 
sphingomyelin (l4©9^) than the beta band (lO,9^) 
but lysolecithin was present in approximately 
equal amounts. Of the total LDL phospholipid,
47^ was present in the slow band.
CHAPTER 6
DISCUSSION
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Immunochemical Findings in Low Density Fraction; 
The observations described in Chapter 4 show that, 
in a high proportion of subjects with obstructive 
jaundice due to various causes, or biliary cir­
rhosis, an abnormal lipoprotein appears within 
their LDL fraction, in addition to beta lipo­
protein* This abnormal lipoprotein was identi­
fied as a form of alpha lipoprotein on the basis 
of the immunochemical studies which are summarised 
as follows,
1© On immunoelectrophoresis in agar gel the LDL 
fraction of the subjects was found to contain a 
normal beta lipoprotein precipitin arc, and an 
abnormal cathodal-migrating lipoprotein precipitin 
arc when antisera with combined anti-alpha and 
anti-beta lipoprotein reactivity were employed* 
This abnormal arc was not obtained with either of 
2 monovalent anti-beta lipoprotein antisera, 
Immunoelectrophoresis in agarose gel also demon­
strated an additional precipitin arc of mobility 
closely/
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closely similar to that of heta lipoprotein*
2o On immunodiffusion, the LDL fraction 
produced an additional precipitin line, peri­
pheral to the beta lipoprotein precipitin line, 
with antisera with anti-alpha lipoprotein 
reactivity, but not with those with anti-beta 
lipoprotein reactivity only*
3o The additional precipitin line, and that 
representing beta lipoprotein, seen on immuno­
diffusion were not found in the supernate of 
the LDL fraction which had previously been 
reacted with an excess of antiserum with anti­
alpha and anti-beta lipoprotein reactivity* 
Similar treatment of the LDL fraction with mono- 
specific anti-beta lipoprotein antiserum led to 
the removal of the beta lipoprotein precipitin 
line only*
4* The LDL fraction was capable of absorbing 
the anti-alpha lipoprotein reactivity from an 
antiserum*
5./
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5, Etber-delipidation of the LDL fraction
led to the disappearance of the abnormal 
precipitin line seen on immunodiffusion and 
the production of a new line, internal to the 
beta precipitin line, and giving a reaction of 
partial identity with alpha lipoprotein. Delipid, 
ation also led to the disappearance of the 
additional arc seen during agarose gel immuno— 
electrophoresis, and the appearance of an arc 
with the approximate mobility of alpha lipo­
protein©
These findings strongly suggest that the 
abnormal lipoprotein constituent of the IDL 
fraction is a form of alpha lipoprotein.
Paper Electrophoresis of Low Density Fraction;
In Chapter the IDL fraction of the same 
subjects was shown, on paper electrophoresis, 
to contain an additional lipoprotein band 
which, although it did not usually stain with 
Oil red 0, was found to contain lipid* It 
is/
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is probable that this new lipoprotein band 
is the counterpart of the abnormal alpha lipo­
protein form recognised in the LDL fraction by 
the immunochemical procedureso Confirmation
of this assumption awaits the demonstration of 
the presence of alpha lipoprotein within the 
band*
Such a lipoprotein band has not been 
previously described though it may correspond 
to the additional component with slower mobil­
ity than beta lipoprotein reported by Kunkel 
and Ahrens (1949) during free electrophoresis 
of sera from 3 of 4 subjects with biliary 
cirrhosis and very high lipid levels.
The failure of the band to stain with 
Oil red 0 despite the presence of lipid requires 
explanation. An alcoholic solution of Oil red 
0 stains fat since the Oil red 0 is more sol­
uble in fat than in alcohol; non-polar lipids 
such as triglyceride take up the stain better 
than/
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than polar lipid such as phospholipid (Chayen 
et al, 1969).
Theoretical models of alpha lipoprotein 
structure suggest that the polar phospholipids 
are situated at the surface of the complexes 
(Scanu, 1969) and that most of the non-polar 
lipid is confined to the interior* The lipid 
extracted from the slow hand was shown, hy 
thin-layer chromatography, to he predominantly 
lecithin and free cholesterol, the main lipids 
which have been found to accumulate in the 
plasma and in the various abnormal lipoprotein 
fractions which have been identified by other 
workers in the jaundiced subjects (Eder et al, 
1955} Buss et al, 1956, Switzer, 1967, Seidel et 
al, 1969). It is possible that the excess phos­
pholipid of the abnormal complex accumulates at 
the surface and prevents access of the Oil red 
0 to the non-polar lipid within the interior* 
Alpha Lipoproteins in Obstructive Jaundice: 
Earlier/
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Earlier observations on the alpha lipoproteins 
in obstructive jaundice, including biliary 
cirrhosis, suggested that they were diminished 
or absente Eor example, Kunkel and Slater 
(1952), using zonal electrophoresis on potato 
starch, found the serum of 5 subjects with 
hyperlipidaemia and biliary cirrhosis, and of 
2 subjects with extra-hepatic biliary obstruct­
ion, to have very low or absent alpha lipo­
protein peakso They commented on the 
apparently contrasting findings of Barr et al 
(1931) who found, in patients with biliary 
cirrhosis, an increase in the Cohn fraction 
carrying the alpha component of normal serum.
To resolve this paradox they suggested that 
the high phospholipid content of the lipoproteins 
of the pathological sera, or their high bile salt 
levels, altered their solubility so that they 
were obtained in the Cohn fraction containing 
alpha lipoprotein*
As/
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As briefly described in Chapter 2, the 
chemical findings were elaborated by Eder et 
al (1955) in a study of 7 patients with primary 
biliary cirrhosis, 5 with secondary biliary 
cirrhosis and 12 with bile duct obstruction, 
using Cohn method no. 10 (Cohn et al, 1950) for 
the fractionation of the plasma proteins. They 
found the increased plasma cholesterol in their 
subjects to be mainly present in Cohn fraction 
IV + V + VI which normally contains alpha lipo­
protein, The phospholipids were proportion­
ately increased so that the cholesterol:phos- 
pholipid ratio of the fraction was close to 
the normal of 1:2. Almost all of the choles­
terol in the fraction was non-esterified. 
Similar changes were found in some subjects in 
the early obstructive stage of acute hepatitis*
Examination of Cohn fraction IV + V + VI 
by lipoprotein paper or starch electrophoresis 
showed/
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showed all the lipids to migrate with the 
mobility of beta globulin* Poor correspond­
ence was also observed between the percentage 
of total cholesterol and phospholipid in the 
d > 1*063 fraction obtained by ultracentri­
fugation, and that in Cohn fraction IV + V + VI, 
there being much less lipid in the former. For 
example, in 3 subjects the d > I0O63 fraction 
contained 3 - 11^ of the total plasma chol­
esterol and 5 - 15^ of the total phospholipid; 
corresponding figures for the Cohn fraction were 
39 - 83^ and 41 - 82^* These findings indicated 
that the greater part of the lipid in Cohn frac­
tion IV + V + VI was of d < 1*063o It was 
concluded that an abnormal lipoprotein occurred 
in obstructive jaundice and speculated that 
either the abnormality consisted of the accumul­
ation of lipoproteins which are normally present 
in small amounts, or that the lipid binding 
capacity of normal lipoproteins were altered, 
possibly/
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possibly as a result of the accumulation of 
bile acids.
The abnormal lipoprotein with the Cohn 
fractions IV + V, and VI was isolated by Russ 
et al (1956); their findings are discussed in 
Chapters 2, and especially, in Chapter 8, They 
too showed the lipids of Cohn fractions which 
normally contained alpha lipoprotein to be un­
usual and to resemble in their preparative and 
analytical ultracentrifugal behaviour, density 
and electrophoretic mobility beta lipoprotein. 
Nevertheless, the fraction failed to react with 
an anti-beta lipoprotein antiserum,
Furman and Conrad (l957) using the analytical 
ultracentrifuge and employing a solvent density of 
1,21 G/ml concluded that obstructive jaundice is 
characterised by reduced or absent HDL (d > 1,063) 
of flotation rate -S^ 2^0-20.
The presence of alpha lipoprotein within the 
liDL fraction of subjects with obstructive jaundice 
was/
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was implied by the work of DeLalla et al (l957)« 
They prepared an anti-alpha lipoprotein anti­
serum in the rabbit using, as an antigen, aged 
acid-citrate-dextrose human plasma from which 
alpha lipoprotein was derived by ethanol pre­
cipitation and subsequent purification by ultra­
centrifugation, This antiserum reacted with the 
d < 1,063 lipoprotein from the patient previously 
described by Russ et al (l956) but did not react 
with normal LDL.
Etienne et al (1966) reported the presence, 
on Immunoelectrophoresis of serum from patients 
with complete biliary obstruction, of a lipo­
protein fraction of only slight mobility ("mobil­
ité très faible") most often migrating behind the 
beta lipoproteins and having the antigenic speci­
ficity of alpha lipoproteins, although no details 
of these properties were given. This abnormal 
fraction was found within the density range 1.020
1.063.
The/
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The recognition, in the present study, of 
an alpha lipoprotein of unusually low density, 
decreased electrophoretic mobility and unusual 
staining properties explains the altered pro­
perties of the lipoproteins found by Eder et 
al (1955) and Russ et al (l956) within the 
Cohn fractions which normally contain alpha 
lipoprotein. Evidently the alterations in 
alpha lipoprotein responsible for its decreased 
density and the resultant alterations in its 
ultracentrifugal properties, and its reduced 
negative surface charge, do not displace it 
into the beta lipoprotein containing Cohn 
fractions.
Other Reports of Abnormal Low Density Lipo­
protein; During or after the completion of 
the present work, 2 closely related papers 
appeared,
A new lipoprotein, the "obstructive 
jaundice/
- 89 -
jaundice lipoprotein" or "OLP" was reported by 
Switzer (1967) to be present in the LDL fraction 
of subjects with biliary obstruction* He studied 
an unspecified number of patients with surgically 
proven, complete biliary obstruction due to a 
variety of causes* Using a gamma globulin pre­
paration of an antiserum against d < I.O63 lipo­
proteins from normal fasting human subjects, he 
found the sera of some or all of these patients 
(this is not specified) to contain a large amount 
of non-precipitable d < 1,063 lipoproteins. By 
comparison, the sera of subjects free of hepatic 
disease, including some with familial hyper- 
cholesterolaemia, contained only negligible 
amounts of unreactive d < 1,063 lipoproteins, 
Imraunoelectrophoretic and double diffusion studies, 
using a commercial antiserum to d < 1,063 lipo­
proteins, confirmed the removal of all normal 
lipoprotein of d < I.O63 by the antiserum*
, The/
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The non-reactivity of these d < 1*063 
lipoproteins did not seem to be explained, on 
the basis of various experiments, by the 
formation of soluble antigen-antibody complexes 
or by the interference with the antigen-antibody 
reaction by serum components such as conjugated 
bile acids*
Switzer (1967) prepared OliP by
(a) precipitating reactive d < 1,063 lipoproteins 
with the antiserum to d < 1,063 lipoproteins.
(b) recovering the unreactive d < 1,063 lipo­
proteins by repeated precipitation with 
mepesulfate*
(c) ultracentrifugation at d 1*063,
The amino-acid composition of this OLP pre­
paration most nearly resembled that of the 
d < 1,006 lipoproteins.
Rabbits were immunised with the OLP prepar­
ation, The resulting antisera reacted strongly 
with the OLP used for their preparation and 
with/
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with freshly prepared OLP* It did not react 
with the d > 1*006 fraction from normal serum 
hut reacted, variably, with the d < 1*006 
fraction, A single, commercial antiserum to 
the d 1*063 « 1*21 fraction (rabbit anti-alpha^ «• 
lipoprotein antiserum) and antisera to d < I.O63 
determinant did not react with the most purified 
preparations of OLP* He concluded that OLP 
contained an antigenic determinant distinct from 
that found in normal d 1,006 — 1,063 lipoproteins 
but common to the one present in some d < 1*006 
fractions prepared from normal serum.
It may be asked whether the OLP of Switzer 
and the abnormal low density alpha lipoprotein 
observed in the present study are identical* The 
evidence offered by Switzer against OLP being 
alpha lipoprotein consists of (a) its amino- 
acid composition which most closely resembled 
that of d < 1,006 lipoprotein. However, as he 
points out, the results were vitiated by the 
contamination/
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contamination of the OLP hy the gamma globulin 
preparation of the antiserum to the d < 1*063 
lipoprotein used in the preparation of the OLP,
(b) the failure of the single commercial anti- 
human alpha^ lipoprotein antiserum to react with 
the purest OLP preparation. This point is dis­
cussed shortly*
Seidel et al (1969) have also described a 
new lipoprotein characterising obstructive jaun­
dice which they designated "LP«X" (LP—X is defined 
by these workers as a lipoprotein occurring in 
obstructive jaundice and characterised by the 
presence of apolipoprotein X)*
The new lipoprotein was isolated as follows. 
The d > 1*006 fraction was acquired from plasma 
by preparative ultracentrifugation and precip­
itated with heparin. The precipitate was 
fractionated by the method of Cohn et al (l930); 
the fractions IV + VI containing LP—X, The
behaviour of LP—X bore a close resemblance to 
that/
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that of the low density alpha lipoprotein 
described here* It showed a cathodal mobility 
on immunoelectrophoresis in agar gel and an 
anodal mobility in agarose gel similar to that 
of the abnormal alpha lipoprotein. On paper 
electrophoresis it migrated just proximal to 
the beta lipoprotein band, A small amount of 
LP-A (lipoproteins characterised by the presence 
of apolipoprotein A) ivas also identified, by 
these workers, within the LDL fraction but, as 
measured in 2 subjectsj, it merely accounted for 
2^ of the total protein content of the fraction* 
LP—X had a protein and lipid composition 
similar to the OLP of Switzer (l96?) and the lipo­
protein of Cohn fraction VI of the patient of Russ 
et al (1956)0
It was also characterised immunochemically* 
Antisera to LP—X were prepared in rabbits* They 
did not react with normal HDL* Conversely, LP-X 
itself did not react with a monovalent anti—alpha^ 
lipoprotein/
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lipoprotein antiserum (Bebringwerke, AG*) or an 
anti-whole human serum antiserum (Bebringwerke,
AG. )#
It is likely that the abnormal lipoprotein 
arcs seen on agar and agarose gel immunoelectro­
phoresis by Seidel et al (1969) are identical to 
those observed in the present study, so that LP-X 
may be the abnormal form of alpha lipoprotein.
If this is so, the failure of LP-X to react with 
anti-alpha lipoprotein antisera has to be accounted 
for*
One possibility is that Seidel et al (1969), 
like Switzer, used an insufficient variety of anti- 
alpha lipoprotein antisera to exclude the abnormal 
lipoprotein form being alpha lipoprotein* It is of 
interest that their commercial monovalent anti- 
alpha lipoprotein antiserum was derived from the 
same source as that of Switzer (1967), In the 
present study 10 antisera in which anti-alpha lipo­
protein reactivity had been previously demonstrated 
were/
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were employed and several did not consistently 
react ifith the abnormal lipoprotein. Recently, 
it has been shown that, contrary to previous 
findings, at least 2 major peptides can be 
identified in alpha lipoprotein, a newly describ­
ed peptide characterised by C-terminal glutamine 
(R-Gln) and the previously described R-Thr 
(shore and Shore, 1968), Small amounts of the 
2 peptides recently found to be major constit­
uents of VLDL, R-Ala and R-Val (Bro^ vn et al, 1969) 
have also been identified in HDL (Fredrickson, 
1969)* Each of these major or minor peptides 
may act as antigenic determinants and a given 
antiserum regarded as having anti—alpha lipo­
protein reactivity may not react with all the 
determinants. Conceivably, the amounts of these 
various peptides relative to each other may be 
altered in the abnormal alpha lipoprotein form; 
it is subsequently suggested in Chapter 11 that 
this abnormal form results from overlipidation 
of/
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of alpha lipoprotein, and since R-Gln may play 
a greater part in lipid binding than R-Thr 
(Gotto, 1969, Gotto and Shore, I969). The 
former peptide may be especially present in the 
abnormal form.
The excess of lipid in the abnormal alpha 
lipoprotein may also mask some of the antigenic 
determinants. It is held, for example, that 
the failure of native VLDL to react with anti­
alpha lipoprotein antisera is due to the large 
proportion of lipid in the molecular complex, 
since following partial delipidation anti-alpha 
lipoprotein antisera readily react with VLDL 
(Levy et al, 1966)*
Support for the view that the LP-X is 
alpha lipoprotein with altered electrophoretic 
mobility also comes from Etienne et al (1966) 
who, as described above, found a precipitin line 
on immunoelectrophoresis, using anti-alpha lipo­
protein antiserum, with a mobility approximating 
to/
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to the abnormal line reported by Seidel et al 
(1969) and in the present work.
Seidel et al (1969) suggest that LP-X is 
present in all subjects with obstructive jaun­
dice, They found it in the plasma of 38 
patients in whom obstructive jaundice had been 
demonstrated by various other tests, but not 
in 23 patients in whom the causes of jaundice 
were non-obstructive*
The present findings differ in that only 
9 of the 21 subjects showed an abnormal lipo­
protein, its presence being related to the extent 
of the lipid and lipoprotein changes (see Chapter
10).
The relative amounts of beta and alpha lipo­
protein within the LDL fraction of subjects nos* 
13 - 21 was not determined in the present study* 
Preliminary results were obtained, however, for 
the percentage of the total LDL cholesterol or 
phospholipid transported in the slow band; it 
was/
-  98 -
was found to carry 59 "• 11$ of the cholesterol 
and 47^ of the phospholipid (Tables 5*1 and 5*2)*
On the assumption that the slow band corresponds 
to the immunochemically identifiable low density 
alpha lipoprotein form, and that the latter is the 
equivalent of LP-X, then these figures are in 
broad agreement with the findings of Seidel et al 
(1969); they attributed 30 - 50^ of the total 
serum cholesterol, and 50 - 80^ of the total serum 
phospholipid to their LP-X fraction, most of the 
balance also being within the LDL fraction in 
LP-B* The present and their findings suggest that 
alpha lipoprotein is present in substantial amount, 
sometimes in excess of beta lipoprotein, in the LDL 
fraction*
CHAPTER 7
HYPERBETALIPOPROTEINAEMIA IN 
OBSTRUCTIVE JAUNDICE
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This chapter presents evidence that, in 10 
of the 21 subjects with obstructive jaundice or 
biliary cirrhosis, beta lipoprotein was the sole 
lipoprotein within the LDL fraction* Taken in 
conjunction with the findings in Chapter 10, it 
establishes that hyperbetalipoproteinaeniia can . 
occur in these disorders*
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The plasma of subjects 1 - 1 0  was examined by 
lipoprotein paper electrophoresis. Six (no. 1, 2,
3, 8, 9 and lO) showed sharp lipoprotein bands of 
beta mobility and of above average intensity on 
visual inspection (Fig* 7°l), corresponding to 
their raised LDL cholesterol levels of 317, 309,
257, 257, 563 and 234 mg/lOO ml respectively (Table 
10,10), Three (no. 4, 5 and 6) showed beta lipo­
protein bands of normal intensity (Fig. 7*l) and 
their LDL cholesterol level was normal or only 
slightly elevated at 209, 147 and 183 mg/lOO ml 
respectively. The remaining subject (no. 7) had 
a weakly staining beta lipoprotein band and a beta 
lipoprotein cholesterol level of only I36 mg/lOO ml. 
The beta lipoprotein bands were of normal width in 
all the subjects* A diminished alpha lipoprotein 
band was observed for each subject and pre-beta 
lipoprotein was usually absent*
On lipoprotein paper electrophoresis of the 
LDL fraction of subjects 1 - 10 a single band of 
beta/
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beta mobility was observed* For example, Fig. 7.2 
shows the findings in subjects no* 1, 2 and 3 and 
in a control subject. The sharp, intensely stain­
ing bands of the patients contrast with the normal 
band of the control subject. When albumen was 
omitted from the barbital buffer and corresponding 
strip stained for lipid with Oil red 0 and protein 
with bromophenol blue, a single protein band of 
identical mobility to the lipid staining band was 
seen (Fig. 7*3)o
Immunoelectrophoretic analysis of the LDL 
fraction in agarose also gave findings consistent 
with beta lipoprotein being the sole lipoprotein 
in the fraction, when various anti-beta lipoprotein 
antisera, including several with anti-alpha lipo­
protein reactivity, were employed. This is 
illustrated in Fig, 7*4 in which the polyvalent 
antisera 79 and 81, both with anti-alpha and anti­
beta lipoprotein reactivity, have yielded a single 
sharp lipoprotein precipitin arc of beta mobility.
The/
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The LDL fraction was also examined by immuno­
diffusion in Ouchterlony plates. When the fraction 
was diffused against a monovalent anti-beta lipo­
protein antiserum such as 36O or an antiserum with 
anti-alpha and anti-beta lipoprotein reactivity 
such as 124A (Fig, 7•5)9 it consistently yielded a 
single precipitin line which gave a reaction of 
identity with a corresponding preparation from a 
control subject.
It was further sho™ that this line was no 
longer obtainable from the LDL fraction after it had 
been reacted with a monovalent or bivalent anti­
beta lipoprotein antiserum. The procedure was as 
follows; 0.1 ml samples of each LDL fraction were 
reacted with three different volumes (O.O3 ml, 0,08 
ml, 0.10 ml) of a gamma-globulin preparation of 
antiseruii 36O or 124A* Similar preparations were 
set up in which 0*1 ml EDTA-saline replaced the 
antisera* The preparations were stored at 4^ for 
72 hrs, centrifuged and the supernates obtained. 
Samples/
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Samples of these and of the unreacted LDL fraction 
were examined hy immunodiffusion in agar gel against 
antisera 124A, 360, AHS and 79, all of which had 
Icnown anti-beta lipoprotein reactivity (Fig. 7*6). 
The untreated and the EDTA-saline diluted LDL 
fractions from each subject produced a single beta 
lipoprotein precipitin line with each of the anti­
sera. This line was absent from the LDL fractions 
which had been previously reacted with either of 
the 2 antisera, although the amount of antiserum 
required for its complete removal varied for 
different subjects, showing a direct relationship 
with the LDL cholesterol concentration.
The counterpart of these findings was obtained 
when the samples were examined by immunoelectro­
phoresis in agar gel; as shown in Fig, 7#7, a beta 
lipoprotein precipitin arc has resulted from the 
LDL fraction treated with EDTA-saline; its weaker 
intensity compared with the corresponding arcs 
obtained with native LDL (Fig. 9.5) is due to the 
four-fold/
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four-fold dilution of the fraction. This arc 
is no longer found in the supernates from the LDL 
fractions which were reacted with either of the 
anti-beta lipoprotein antisera.
Lipoprotein paper electrophoresis also con­
firmed that the lipoprotein band of beta mobility 
observed within the LDL fraction was completely 
removed by appropriate amounts of antisera (Fig* 
7.8).
A further series of experiments were designed 
to assess whether lipid, other than beta lipo­
protein, could be identified with the LDL fraction 
employing the sensitive technique of thin-layer 
chromat ography•
The relative volumes of the antisera required 
for complete removal of beta lipoprotein from the 
LDL fraction having been determined as described 
above, 0*3 ml of the LDL fraction was added to 
0.3 ml or 0.5 ml of the gamma-globulin preparation 
of antiserum 124A or 360, Similar preparations of 
0.3/
- 105 -
0,3 nil of the LDL fraction and 0,3 ml or 0,5 ml 
of EOTA-saline, and of Oo3 ml EDTA-saline and 0,3 
ml or Qo5 ml of antiserum 124A or 3^0 were set up. 
The supernates were recovered and 0,4 ml of each 
was extracted with 10 ml chloroformnnethanol 
(2:1 vol:vol); 2 ml of acidified water was added, 
the resulting phases were permitted to separate and 
the chloroform phase was recoveredo 0,75 ml 
aliquots of this phase were taken to dryness, re­
dissolved in a small volume of chloroform and 
analysed by one-dimensional thin-layer chromato­
graphy using polar or non-polar solvent systems.
The plates were stained for lipid by anisaldehyde. 
The samples derived from the saline-diluted 
LDL fractions showed, with the non-polar solvent 
system, spots corresponding to free and ester chol­
esterol, and triglyceride (Figs. 7.9a and 7.9b). 
With the polar system these samples produced 
lecithin and sphingomyelin spots and, to a lesser 
extent, phosphatidyl ethanolamine and phosphatidyl 
serine/
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serine spots (Figs, 7.10a and 7.10b).
The corresponding samples derived from the 
LDL fractions which had been reacted with either 
of the antisera showed faint free and ester 
cholesterol, and phosphatidyl ethanolamine lipid 
spots only; these were similar in intensity to 
the spots obtained from the samples derived from 
the saline-diluted antisera, suggesting that the 
small amount of lipid observed in the supernate 
of the LDL fractions which had been reacted with 
the antisera originated from the antisera them­
selves. This interpretation is reinforced by 
the observation that these spots were also present 
in the antibody treated fraction from the control 
subject (Figs, ?.9b and 7*10b).
VLDL Fraction; As was described for some of the 
subjects described in Chapter a lipoprotein 
band of beta mobility was observed on paper 
electrophoresis of the VLDL fraction of 6 of the 
10 subjects. This finding is discussed in 
Chapter/
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Chapter 12.
HDL Fraction: This fraction behaved normally on
lipoprotein paper electrophoresis and on iimnuno- 
electrophoresis except that it appeared reduced in 
amount in keeping with the findings for the whole 
plasma*
CHAPTER 8
DISCUSSION
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It is generally agreed that, in biliary 
cirrhosis and in different forms of obstructive 
jaundice, a characteristic disturbance in the 
plasma lipids occurs consisting of a marked 
increase in phospholipid and a less pronounced 
rise in total cholesterol, especially its 
esterified form* Triglyceride levels are only 
sometimes elevated and lipaemia does not occur 
(Man et al, 19^5, Ahrens et al, 1950)o
The application of electrophoretic and ultra­
centrifugal methods of analysis suggested that an 
increase in the beta lipoprotein fraction was 
partly or totally responsible for the elevated 
lipidso By means of free electrophoresis, Kunkel 
and Ahrens (1949) showed that a rise in beta 
globulin levels consistently occurred in patients 
with primary biliary cirrhosis* They found the 
area of the beta globulin peaks to be directly 
proportional to the total serum lipid concentration 
Partial delipidation of the sera produced a con­
siderable/
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considerable reduction in the beta globulin com­
ponents, in keeping with their being responsible 
for the transport of the excess lipid. Similarly 
Sterling and Ricketts (1949) studied 10 subjects 
with biliary cirrhosis which had developed follow­
ing cholecystectomy for cholelithiasis* They 
showed, by free electrophoresis, that beta globulin 
levels were increased, sometimes strikingly so.
They attributed this to an increase of a lipoprotein 
since they observed ether extraction of the sera to
reduce the beta globulin peaks by about 66^*
Zonal electrophoresis, with starch as the 
supporting medium, was subsequently employed by
Kunkel and Slater (l95%), who found the sera of 5
subjects with biliary cirrhosis to show a very high 
peak with a mobility approximating to that of normal 
beta lipoprotein. Analysis of an extract of this 
peak showed it to consist predominantly of phospho­
lipid, In discussing the compositional changes 
observed in the "beta lipoprotein" they suggested 
that/
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that the lipoprotein was prohahly related to normal 
beta lipoprotein but had assumed a different com­
position; alternatively they postulated its being 
an entirely different lipoprotein of beta mobility.
Further evidence for an increase in beta 
lipoprotein was provided by McGinley et al (l952) 
using the analytical ultracentrifuge. They 
reported striking increases in the 6 and 8 
lipoprotein classes and variable increases in the 
10 - 17 classes.
Eder et al (l955) studied 12 patients with 
primary or secondary biliary cirrhosis, and a 
similar number with bile duct obstruction. Using 
lipoprotein paper electrophoresis they found almost 
all of the stainable lipid to migrate to the beta 
lipoprotein area, the alpha component being 
negligibly small. Flotation studies in the pre­
parative ultracentrifuge of the plasma of 3 subjects 
with biliary cirrhosis correlated with the electro­
phoretic findings, in that only a small proportion 
of/
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of the total serum cholesterol and phospholipid 
was in the fraction d > 1.063* A warning that 
conventional operational methods of defining the 
beta lipoproteins might be unreliable in these 
disorders was provided by their other observations* 
They fractionated the plasma proteins by Cohn 
method no 10 (Cohn et al, 1950) and found the 
increase in total plasma cholesterol to be due to 
its accumulation chiefly in Fraction IV + V + VI 
in which alpha lipoprotein is usually found. This 
fraction, however as studied in one subject,had the 
paper electrophoretic mobility of beta globulin, as 
did the lipoprotein of Fraction I + III which 
normally contains beta lipoprotein* Both frac­
tions were of d < 1.063* The abnormal lipoproteins 
were also observed in the early stages of the 
jaundice of acute hepatitis when intrahepatic 
obstruction of finer biliary radicals are a possible 
feature.(Watson and Hoffbauer, 1947)©
These observations were extended, in a single 
subject/
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subject with xanthomatous biliary cirrhosis, by 
Russ et al (1956), Having fractionated the 
plasma by Cohn method no 10 and examined the 
density gradients of the lipoproteins floated 
from the fractions, they found the lipids of 
Fraction IV + V to have the paper electro­
phoretic mobility of beta^ and beta^ globulins, 
to be concentrated in the density range 1,041 - 
1,042, and to show compositional changes in 
the direction of a greatly reduced cholesterol: 
phospholipid ratio, a high free cholesterol; 
cholesterol ester ratio, and a low peptide:lipid 
ratio. Fraction VI also contained a lipoprotein 
which, on paper electrophoresis, dragged from the 
origin through the beta^ globulin area* This 
fraction had 2 peaks of lipid concentration; 
one peak in the density range 1.035 - 1,038, and 
another in the range 1.039 - 1.049©
The major lipoprotein concentration of 
Fraction I + III appeared in the density gradient 
tube/
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tube at 1*036 - 1.040, a slightly higher density 
range than normal, and its compositional features 
differed widely from normal beta lipoprotein. 
Nevertheless this fraction contained the anti­
genic determinant of beta lipoprotein giving 
precipitin reactions with antiserum against all 
the low density lipoproteins of normal plasma; 
the other Cohn fractions failed to react.
The flotation rates of each of the fractions 
were determined in the analytical ultracentrifuge. 
Fraction VI showed 3 species 25, 29 and
16. Fraction IV + V consisted of 2 species 
mainly 13 and a little 6, Fraction I +
III almost entirely contained 5 molecules.
In summary on the basis of moving boundary 
and zonal electrophoresis, analytical and prepara­
tive ultracentrifugation, and Cohn fractionation, 
there is evidence that beta lipoprotein is increased 
in biliary cirrhosis and obstructive jaundice* That 
this evidence may be suspect is suggested by the 
anomalous/
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anomalous reports just described, by other findings 
describing alpha lipoproteins (Etienne et al, 1966) 
or so-called "obstructive jaundice lipoprotein" or 
lipoprotein-X (Switzer, 196?, Seidel et al, I969) 
within the LDL fraction as discussed in detail in 
Chapter 6, and by the evidence from the present study 
for the presence of alpha lipoprotein in the LDL 
fraction discussed in the same chapter. These 
various findings make it difficult to draw conclusions 
from the previous studies purporting to have demon­
strated an increase in beta lipoprotein levels.
The findings of the present study offer strong 
evidence for the LDL fraction of the 10 patients 
described in the previous chapter consisting solely 
of beta lipoprotein* They are, in summary -
1, The LDL fraction migrated as a single band of 
beta globulin mobility on paper electrophoresis either 
when a lipid or a protein stain was employed.
2. The LDL fraction yielded a single lipid-stain- 
ing precipitin arc of beta mobility when examined by 
immunoelectrophoretic/
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inunuBoelectrophoretic analysis in agarose or 
agar gels using monovalent or polyvalent anti­
beta lipoprotein antisera.
3o The LDL fraction produced a single lipid- 
staining precipitin line when immunodiffused 
against anti-beta lipoprotein antisera, and 
this line gave a reaction of identity with that 
obtained using normal beta lipoprotein,
4o The bands obtained on paper electrophoresis, 
and the precipitin arcs and lines observed on 
immunoelectrophoresis and immunodiffusion 
respectively, were no longer obtainable from the 
supernates of the LDL fractions which had been 
previously reacted with monovalent or polyvalent 
anti-beta lipoprotein antisera*
5o Examination of these supernates for lipid by 
a highly sensitive method (TLC) showed trace 
amounts only, and this could be attributed to the 
excess of the antisera.
Since the lipid within the LDL fraction of 
these/
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these subjects appears exclusively in beta lipo­
protein it is possible to assess whether this 
fraction is increased in concentration.
The LDL cholesterol concentration of each 
of the subjects is given in Table 10,10. The 
values may be compared with the age-related 
upper normal limits for LDL concentration in 
Table 10*1 which vary from 170 - 210 mg/lOO ml. 
The use of beta lipoprotein cholesterol levels 
as a measure of beta lipoprotein concentration 
is based on the assumption that beta lipoprotein 
composition is fairly constant* Compositional 
changes were observed in the LDL fraction of the 
relevant jaundiced subjects (Tables 10,15 and 
IO0I6, and see Chapter lO) but they were minor 
for cholesterol; this lipid contributed 
36.8 i 2.4^ by weight of the fraction of the 5 
control subjects and 32.4 Ï 4.8^ of that of the 9 
jaundiced subjects, the difference being 
statistically/
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statistically insignificant. Further, the percent­
age of cholesterol in the LDL fraction of normal 
subjects is usually taken somewhat higher (Table 1.2), 
Accordingly the cholesterol component of the LDL 
fraction of the jaundiced subjects tends to be low, 
so that the procedure for quantifying their beta lipo­
protein generally underestimates the total beta 
lipoprotein concentration. The LDL cholesterol 
concentration of all but 2 (no. 5 and 7) of the 
10 subjects fell beyond the corresponding upper 
95^ confidence limits, often substantially, and the 
mean value for the group was high at 26l mg/lOO ml.
It is, therefore, concluded that hyperbetalipo- 
proteinaemia occurs in certain subjects with 
jaundice due to intra- or extra-hepatic obstruction 
or biliary cirrhosis. This hyperbetalipoprotein- 
aemia may be one of the several consequences of the 
lipid retention directly or indirectly due to intra- 
or extra-hepatic cholestasis; this is further 
discussed in Chapter 11.
CHAPTER
LOW DENSITY FORM OF ALPHA LIPOPROTEIN 
RETAINING NORMAL ELECTROPHORETIC MOBILITY
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The identification of an alpha lipoprotein form, 
within the LDL fraction of 2 jaundiced subjects, is 
described in this chapter. Unlike the abnormal 
alpha lipoprotein of the subjects described in 
Chapter 5j it showed little or no alteration in its 
electrophoretic mobility*
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On lipoprotein paper electrophoresis the 
whole plasma of subjects nos, 11 and 12 showed 
a prominent lipoprotein band with the approxi­
mate mobility of normal alpha lipoprotein, and 
a beta lipoprotein band (Fig. 9#l). The LDL 
fraction of both subjects produced, on lipo­
protein paper electrophoresis, in addition to a 
beta lipoprotein band, a faintly staining band 
of alpha^ mobility (Fig, 9.2), Both these LDL 
bands also stained for protein with broraophenol 
blue. The HDL fraction of each subject contained 
a prominent alpha lipoprotein band only (Fig,
9.3).
As was seen for many of the subjects in the 
other groups, the VLDL fraction of subject no,
11 contained a band of electrophoretic mobility 
similar to that of normal beta lipoprotein (Fig.
9.4), It was not observed in the VLDL fraction 
of subject no, 12.
The presence of alpha lipoprotein within the
LDL/
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LDL fraction of these subjects was confirmed on 
immunoelectrophoresis. For example, Fig, 9*5 
shows the LDL fraction of subject no* 11 to con­
tain 2 lipoprotein precipitin arcs; a normal 
beta lipoprotein arc, and a faint, faster moving 
arc of alpha mobility© These arcs were produced 
using antiserum 124A with anti—alpha and anti—beta 
lipoprotein reactivity* When a monovalent anti- 
beta lipoprotein antiserum such as 5^0 was used, 
the alpha lipoprotein precipitin arc was not 
seen, but only the beta lipoprotein arc*
Immunoelectrophoretic examination of the 
whole plasma and the other lipoprotein fractions 
revealed no other noteworthy features*
When the LDL fraction was examined by immuno­
diffusion in an Ouchterlony plate, it showed 2 
precipitin lines against a variety of antisera 
which had, in common, anti—alpha and anti—beta 
lipoprotein reactivity (Fig. 9*6); an outer line 
which was sho%m to be due to beta lipoprotein, 
and/
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and an additional inner line. The inner line 
was not removed from the LDL fraction hy prior 
absorption with monovalent anti-beta lipoprotein 
antiserum 360, It disappeared following the 
reaction of the fraction with antiserum 124 with 
anti-alpha and anti-beta lipoprotein reactivity.
Unlike the additional precipitin line, also 
thought to represent alpha lipoprotein, seen in 
the LDL fraction of the subjects described in 
Chapter 4 (Fig. 4.13) it was internal to the beta 
lipoprotein line and not external.
The plasma lipid levels and lipoprotein com­
position of subjects no, 11 and 12 are described 
in Chapter 10 and the findings are discussed in 
Chapter 11, Here it is convenient to mention 
that the prominent alpha lipoprotein bands observed 
on paper electrophoresis were matched by the high 
HDL cholesterol levels (Table 10,10).
CHAPTER 10
QUANTITATIVE LIPID AND LIPOPROTEIN ALTERATIONS: 
CORRELATION M T H  VARYING BEHAVIOUR 
OP ALPHA LIPOPROTEIN
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The 21 patients with obstructive jaundice 
can be divided into 3 groups according to the 
behaviour of their alpha lipoprotein*
Group I in which, as described in Chapter
7, alpha lipoprotein retained its normal electro­
phoretic and ultracentrifugal characteristics, 
and in which hyperbetalipoproteinaemia was 
demonstrated.
Group II in which, as described in Chapter
8, some alpha lipoprotein was identified at
d < 1,063 but which showed little or no alter­
ation in its electrophoretic mobility.
Group III in which, as described in Chapter 
4, alpha lipoprotein was identified at d < 1,063 
and which showed abnormal electrophoretic mobility. 
In an attempt to clarify the factors respons­
ible for this varying behaviour of alpha lipo­
protein, the plasma lipid and lipoprotein con­
centrations and aspects of the lipoprotein 
composition of these groups were studied and 
compared/
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compared.
Plasma Lipids: The plasma cholesterol, tri­
glyceride and phospholipid levels of each 
subject are shown in Table 10.2 and the mean 
values and standard deviations for each of 
the group in Table 10.3.
Age-related normal limits for cholesterol 
and triglyceride levels which had been pre­
viously established for the Laboratory of 
Molecular Disease (Fredrickson et al, 196?) 
are listed in Table 10.1, and were used for 
comparison. These limits are based on 95^ 
fiducial limits calculated for small samples.
The values for the 50 - 59 decade were also 
used for comparison with the results from 
jaundiced subjects aged 60 and over with respect 
to this and other data. Seventeen of the 21
subjects had cholesterol levels which fell 
above the upper normality limit, often con­
siderably, the highest value being 800 mg/lOO 
ml. The mean value for the whole series was
397/
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397 mg/lOO ml and was significantly higher 
than that of the 5 control subjects, as was 
the values for each of the 3 groups. In 
those subjects in whom lipid levels were 
serially determined, the cholesterol level 
was observed to fall following relief of 
jaundice (Table 10.4). No significant dif­
ferences were noted between the mean chol­
esterol levels of each of the groups.
Triglyceride levels were elevated less 
frequently than cholesterol, exceeding the upper 
normality limit in 12 of the subjects. The 
mean value for the whole series was 200 mg/lOO 
ml which did not differ significantly from that 
of the control subjects, and the highest value 
was 600 rag/lOO ml. The levels fell in one of 
the subjects (no. l6) in whom jaundice was 
relieved (Table 10.4). None of the plasma 
samples were lipaemic, even in 3 subjects whose 
levels ranged from 378 - 642 mg/lOO ml (Table 
10.2/
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10.2), levels at which lipaemia is normally 
apparent. On the contrary, the samples were 
quite clear.
Although the mean triglyceride level of 
each of the groups varied considerably, rang­
ing from 96 mg/100 ml for Group II to 286 mg/
100 ml for Group III, they did not differ 
significantly from one another.
Normal values for total plasma phospho­
lipid levels have not been established for the 
Laboratory of Molecular Diseases. For a broad 
comparison the data of Adlersberg et al (1956) 
was employed ; in Table 10.5 age- and sex- 
related upper normality limits for serum phos­
pholipids were derived from this data by setting 
each upper limit at 2 standard deviations from 
the mean.
Of the 20 subjects in whom phospholipid 
levels were determined, 19 had elevated levels 
(Table 10.2). These elevations were sometimes 
striking/
—  126 —
striking; for example, in 3 subjects they 
exceeded 1,000 mg/lOO ml and in 3 others, 600 
mg/lOO ml. The mean value for all 20 subjects 
was 556 mg/100 ml, and comparison with that of 
the 5 control subjects showed it to be signif­
icantly elevated. Similarly, the values of 
each of the groups was significantly elevated.
The hyperphospholipidaemia was reversible; 
in 2 subjects in whom the initial levels were 
1,062 mg/100 ml and 1,155 mg/lOO ml, the relief 
of the jaundice was associated with falls to 
371 mg/100 ml and 383 mg/lOO ml respectively 
(Table 10.4).
The mean phospholipid levels of the 3 groups 
differed considerably (Table 10.3), ranging from 
393 mg/100 ml for the Group I subjects to exactly 
double for those of Group III. The higher 
level of the latter subjects differed significant­
ly from that of the former, but not from that of 
the 2 Group II subjects who had identical levels 
of/
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of 522 mg/100 mlo The mean level of the Group 
II subjects -was not significantly higher than 
that of the Group I subjects.
Individual subjects in Group III showed 
considerable variation in their phospholipid 
levels (as reflected by the large standard 
deviation of 353 mg/lOO ml) and several had 
values which overlapped those of Group I and 
Group II subjectSo
Free Cholesterol and Cholesterol Ester: The
ratio of free cholesterol: cholesterol ester in 
normal plasma is held within remarkably fine 
limits, shows minimal variations with age and 
sex (Goodman, I965), and is usually taken as 
approximately 1:2* For the purposes of com­
parison with the findings in the jaundiced 
subjects, the normal values given by Eder et 
al (1955) were used in which the free cholesterol; 
cholesterol ester ratio ranges from 22:78 - 35:65o 
The 5 control subjects had ratios within this 
range/
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range (Table 10,6)0 The results for the 
individual subjects are given in Table 10.6,
Seven of the 10 Group I subjects, and all 8 
of the Group III subjects in whom it was 
estimated showed a ratio increased beyond 
those limits. The ratio in each Group III 
subject was grossly disturbed to the extent 
that it was almost totally reversed. Of the 2 
Group II subjects, one had a slightly increased 
ratio. There was no overlap between the ratios 
for the Group III subjects and those of other 
groups.
The mean values for the ratios of each of 
the groups are shoTO in Table 10.7. Those of 
Groups I and III were highly significantly 
elevated in comparison with that of the controls; 
that of Group II was not. The Group III mean 
was significantly higher than the mean for each 
of the other groups, which themselves did not 
significantly differ.
Normal values for plasma free cholesterol
and/
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and cholesterol levels were calculated from 
the age-related normal ranges of total chol­
esterol sho^m in Table 10.1 taking the free 
cholesterol: cholesterol ester ratio as 1:2, 
and are given in Table 10.8. The results 
for the control subjects were normal (Table 
10.6).
The free cholesterol levels (Table 10.6) 
of 8 of the 10 Group I subjects were raised 
above the upper limit, but not to the same 
extent as the 8 Group III subjects in most of 
whom there was a striking rise. One of the 
2 Group II subjects had a slightly elevated 
level. Each of the 3 groups had highly 
significantly elevated means in comparison to 
the controls (Table 10.9).
The mean free cholesterol level of Group 
III (Table 10.9) was considerably and signi­
ficantly higher than that of Group I.
The cholesterol ester levels (Table 10,6)
of/
- 130 -
of the individual subjects showed, for Group I 
a rise in 6 and a fall in 1, for Group II a 
rise in both, and for Group III a fall in 4,
The higher mean level of the Group II subjects 
significantly differed from that of the controls.
The mean cholesterol ester level of the 
Group III subjects (Table 10,9) was significantly 
less than that of the Group II and Group I subjects. 
Lip opr otein Quantificat i on; The lipid and pro­
tein composition of each of the plasma lipoprotein 
fractions shows little variation both in health 
and in most hyperlipoproteinaemic states, so that 
changes in the concentration of a given lipoprotein 
fraction are paralleled by changes in the concen­
tration of its individual lipids. Accordingly, 
Fredrickson et al (l96?) introduced a system of 
quantifying the lipoprotein fractions by estimation, 
directly or indirectly, of the cholesterol concen­
tration of each fraction. It involves estimation 
of/
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of A Plasma total cholesterol level -
(lDL + VUDL + HDL) cholesterol level.
B Cholesterol level of d > 1,006 fraction - 
(LBL + HDL) cholesterol level.
C HDL cholesterol level.
Then A - B - VLDL cholesterol level
B - C = LDL cholesterol level
C “ HDL cholesterol level
Their normal values for LDL, VLDL and HDL chol­
esterol concentrations according to age, and in the 
case of HDL cholesterol also according to sex, are 
sho^m in Table 10,1.
LDL: The LDL cholesterol levels of all but 2 of
the jaundiced subjects.were elevated outside these 
limits; often considerably (Table 10.lO). For
example, subject no. 13 had a LDL cholesterol 
concentration of 579 mg/lOO ml, the upper level of 
normal for a subject of his age being 190 mg/lOO 
ml. However, comparison of the observed LDL 
cholesterol levels with those of normal subjects 
requires/
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requires qualification. Firstly, as has been 
previously described and has been confirmed in 
the present study, compositional changes occur 
in the lipoproteins of these patients. These 
have the effect of reducing the relative contri­
bution of cholesterol to the total LDL concen­
tration and lead to an underestimation of the 
LDL concentration when it is measured in terms 
of the LDL cholesterol concentration. Secondly, 
in the subjects within Groups II and III the LDL 
fraction has been sho^ vn to contain alpha lipo­
protein as well as beta lipoprotein. The 
percentage of cholesterol in alpha lipoprotein 
is normally considerably lower than in heta lipo­
protein (Table 1.2). The compositional changes 
in the alpha lipoprotein of the jaundiced sub­
jects variably alter this figure.
The most meaningful comparison is therefore 
between the subjects in Group I (Table 10.lO), 
whose LDL fraction was shown, in Chapter 7> to 
contain/
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contain beta lipoprotein only, and the normal 
subjects. Eight of the 10 patients in this 
group had elevated LDL cholesterol levels.
Since their LDL cholesterol constituted, on 
average, 32,4^ of the total LDL fraction which 
was lower, though not significantly, than the 
corresponding figure of 36.8^ of the control 
group (Table 10.16)? the degree of hyperbeta- 
lipoproteinaemia as indicated above was slightly 
greater than the figures for LDL cholesterol 
indicate. In addition, the mean value of this 
group was significantly higher than that of the 
controls.
Although the mean values for the LDL chol­
esterol of the groups varied considerably (Table
10,11), they were not significantly different. 
Such a comparison is valid since the mean per­
centage cholesterol content of the LDL fractions 
of the groups also did not differ significantly 
from one another (Table 10.16).
VLDL/
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VLDL; Eleven subjects bad elevated VLDL 
cholesterol levels, 2 had reduced levels and 
7 had normal levels (Table 10,lO). Despite 
a much higher mean level, Group III did not 
differ significantly from Group I or II (Table
10.11) nor did any of the means differ signi­
ficantly from the controls#
HDL; The HDL cholesterol levels of the sub­
jects in each group were estimated following 
either heparin-manganese precipitation of all 
other d < 1.063 lipoproteins (Tables 10.10 and
10.11) or the ultracentrifugal separation of 
the d > 1.063 fraction (Tables 10.13 and 10,14). 
The values obtained by either method correlated 
closely (for all subjects in the 3 groups
r = 0.9125; p < O.OOl).
With the heparin-manganese precipitation 
method (Tables 10.10 and 10.ll), the mean value 
of the Group I subjects at 42 mg/lOO ml was well 
within the range for normal subjects (Table 10.l); 
of/
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of the 10 subjects in Group I the results were
normal in 6, reduced in 3 and elevated in only 1.
Of the Group II subjects 1 had an elevated level 
of 91 mg/lOO ml and the other a level of 87 mg/
100 ml near the upper limit. Eight Group III 
subjects had a mean value well below the lower 
normal limit; the levels of 6 fell into this 
category and only 2 had levels within the normal 
range. The higher value for the Group II sub­
jects, and the reduced value for the Group III 
subjects differed significantly from that of the 
controls, and from one another (Table 10.ll).
The Group II value was also significantly higher
than that of Group I,
There was some overlap between the values 
of the individual subjects of Groups I and III.
The results obtained for the HDL cholesterol 
concentrations of the groups following prepar­
ative ultracentrifugation (Tables 10.13 and 10.14) 
were similar both with respect to the mean values 
and/
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and the statistical differences, except when 
Group I was compared with Group II or III.
HDL Phospholipid; The mean HDL phospholipid 
levels of each of the groups (Table 10.14) 
paralleled the changes in HDL cholesterol levels 
in that Group II had the highest level (213 mg/ 
100 ml) and Group III the lowest (?0 mg/lOO ml). 
These values differed significantly one from the 
other (Table 10.I3).
No published range of normal age-related HDL 
phospholipid levels was available for comparison 
but the value for the Group II subjects was sig­
nificantly elevated over that of the controls. 
Phospholipid;Cholesterol Ratio ; Compositional 
changes in the HDL fraction were assessed by com­
parison of the phospholipid;cholesterol ratio 
(Tables 10,13 and 10.14). This ratio in normal 
HDL is slightly less than 2 (Table 1:2); the 5 
control subjects had a mean ratio of 1.92. Each 
of the 3 groups had mean values considerably 
exceeding/
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exceeding this, which differed highly signi­
ficantly from that of the controls hut not 
from one another.
LDL Composition; The percentage composition 
of the LDL fraction of the whole series of 
jaundiced subjects (Tables 10,15 and 10.16) 
was distinctly different from that of the 5 
control subjects and was characterised by a 
significantly raised percentage of phospholipid 
and a significantly decreased percentage of 
cholesterol and protein. This pattern was also 
seen for the Group III subjects. In Groups I 
and II the percentage of LDL phospholipid was 
significantly raised, as was the percentage of 
protein in the former.
The mean LDL composition of the 3 groups of 
jaundiced subjects were compared with one another. 
Group III showed the greatest deviation from normal 
with 43.6^ of the total non-hydrated weight con­
sisting of phospholipid which differed significantly 
from/
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from that of Group I and Group II, both of which 
had statistically similar mean levels of 32.8^ 
and 34,0^ respectively.
The subjects within Group III had the lowest 
mean LDL percentage protein content at 13#9^ », 
significantly less than that of Group I (22*0^) 
and Group II (26,5^)#
The LDL percentage cholesterol and trigly­
ceride content of the groups were similar.
CHAPTER 11
DISCUSSION
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Plasma Lipids; The changes in the plasma lipid 
levels of the jaundiced subjects conform closely 
to the pattern described by Man et al (l945) and 
Ahrens et al (l950) as outlined in Chapter 2.
This lipid pattern, except when it occurs in 
the rare genetically determined disorder, plasma 
lecithin;cholesterol acyl transferase deficiency 
(Norum and Gjone, 196?), is exclusive to obstruc­
tive jaundice* Its main features, confirmed in 
Chapter 10, are the striking elevation in the 
levels of the plasma phospholipids, a less pro­
nounced but fairly consistent increase in total 
plasma cholesterol levels, and the disruption of 
the normally stable relationship between the 
proportions of free and ester cholesterol (Good­
man, 1963) in favour of an increase in the former, 
The changes in triglyceride levels, here measured 
directly in contrast to the indirect measurement 
of neutral fat by Man et al (l943), are less con­
stant; nevertheless a majority of the subjects 
had/
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had hypertriglyceridaemiao The reversibility 
of these various plasma lipid changes with 
the relief of the jaundice was also confirmed* 
Hyperbetalipoproteinaemia: The study of the
concentrations of the plasma lipoproteins 
described in Chapter 10 taken in conjunction 
with the findings in Chapter 7 established that, 
in almost half of the jaundiced subjects (Group 
l), beta lipoprotein concentrations were increas­
ed. Accordingly, obstructive jaundice can be 
numbered with disorders such as hypothyroidism, 
the nephrotic syndrome, multiple myelomatosis, 
idiopathic hypercalaemia and acute porphyria as 
a cause of acquired Type II hyperlipoproteinaemia 
(Levy and Langer, 19^9)* Unlike the primary 
form and other secondary forms of hyperbetalipo­
proteinaemia, in which beta lipoprotein is 
increased in concentration but remains unaltered 
in composition, the elevated beta lipoprotein in 
obstructive jaundice displayed altered composition. 
It/
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It showed, in comparison with the LDL of 
the control subjects, in respect of its 
percentage composition, significantly increas­
ed phospholipid and decreased protein (Table 
10.16), These changes reverted to normal 
with relief of jaundice. These compositional 
changes are in harmony with those described by 
Eder et al (l955) and Russ et al (l956) for the 
lipoproteins of Cohn fraction I and III. The 
LDL composition of the control subjects differs 
somewhat from that commonly quoted ( One ley and 
Harvie, 1969 and see Table 1,2) in which chol­
esterol, both free and ester, constitutes 
43 - 45^ of the total lipoprotein, and phospho­
lipid and protein each about 22^. However, 
as discussed in Chapter 8, the differences are 
in the direction of magnifying the alterations 
from normal in the composition of the beta 
lipoprotein of the jaundiced subjects belonging 
to Group I,
Low/
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Low Density Forms of Alpha Lipoprotein; The 
LDL (d 1,006 - 1,063) class normally contains 
heta lipoprotein only. Genetic variations 
(polymorphisms) of this normal heta lipoprotein 
have been described, namely the Ag system of 
Blnmberg et al (1962) and the Lp system of 
Berg (1963)0 Rarely the LDL range contains 
lipoproteins other than normal beta lipoprotein, 
In subjects with abetalipoproteinaemia, who 
have a total deficiency of beta lipoprotein, 
there appears a low density lipoprotein with 
alpha^ mobility on paper electrophoresis, and 
which has been further characterised as alpha 
lipoprotein on the basis of immunochemical 
studies and its total amino acid composition 
(Levy et al, 1966),
Recently, Sohdi (1969) detected, in the 
plasma of a healthy 10 year old boy with normal 
serum cholesterol and triglyceride levels, a 
lipoprotein of density between 1.040 and 1,063 
with pre-beta mobility on paper electrophoresis 
and/
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and producing an additional peak in the 
Schlieren pattern on analytical ultracentri­
fugation. This lipoprotein reacted with 
anti-LDL antiserum. The precise nature of
this abnormal lipoprotein form remains to be 
fully characterised.
The present study furnishes 2 further 
examples of abnormal constituents of the LDL 
fraction, namely the low density alpha lipo­
protein forms with altered (see Chapter 4) 
or virtually unaltered (see Chapter 9) electro­
phoretic mobility. The subjects with these 
changes were allocated, in Chapter 10, to Groups 
III and II respectively. Another group of 
subjects (Group I) was defined in terms of alpha 
lipoprotein being confined to its conventional 
density range and displaying normal electro­
phoretic mobility. The subjects of the 3 groups 
showed, as described in Chapter 9, various sig­
nificant differences in the concentration of 
their/
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their plasma lipids and lipoproteins, and in 
the composition of the latter.
The main statistically significant differ­
ences between the mean values of the groups 
were
(1) The Group III subjects had higher phos­
pholipid levels than those of Group I,
(2) The Group III subjects had a higher free
cholesterol level than the Group I 
subjects and a lower cholesterol ester 
level; and a higher free cholesterol: 
cholesterol ester ratio than those of 
Groups I and II,
(3) The Group III subjects had the lowest HDL
cholesterol (measured in the d > 1,063
fraction) and phospholipid levels and 
Group I the highest. Similarly, the 
HDL cholesterol level of Group III 
(measured by heparin—manganese precip­
itation) was significantly higher than 
Group/
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Group II, and that of Group II from 
Group I; however, the difference 
between Groups I and III just failed to 
achieve the 5 $ significance level*
(4) The Group III subjects had, in their LDL
fraction, a lower percentage of protein
and a higher percentage of phospholipid 
than each of the other groups*
It may therefore be asked whether the ultra- 
centrifugal or electrophoretic alterations in the 
properties of alpha lipoprotein were determined 
by the changes in the lipoprotein concentrations 
and composition*
The separation of the plasma lipoproteins 
using the preparative ultracentrifuge is based on 
the different hydrated densities of the classes 
(Table Id), The hydrated density of a lipo­
protein class is a function of its protein and 
lipid composition which is also characteristic 
for each class (Table 1*2)* Since the density 
of/
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of lipid varies from 0,9 - 1*0 G/ml, a roughly 
linear relationship exists between hydrated 
density and protein content (Lindgren and 
Nichols, i960).
The alpha lipoprotein of the Group III 
and Group II subjects may have acquired a higher 
proportion of lipid than normally carried lead­
ing to a fall in its density to below 1*063*
A degree of overlipidation of alpha lipoprotein 
insufficient to reduce its density to 1*063 
might then explain the non-appearance of alpha 
lipoprotein in the LDL fraction of the Group I 
subjects*
Support for these concepts is obtained by 
the comparisons of the lipid and lipoprotein 
changes in the 3 groups, since as summarised 
above, they show the greatest degree of 
hyperlipidaemia (phospholipid, free cholesterol) 
to have occurred in the Group III subjects.
The significantly lower HDL cholesterol and 
phospholipid/
—  147 —
phospholipid levels of the Group III subjects 
in comparison to those of Group I could be 
explained by the conversion of most of their 
alpha lipoprotein into a lower density form, 
leaving only a small amount of alpha lipoprotein 
whose density, albeit probably lowered, still 
remained above 1,063#
The differences in the LDL composition of 
the Group III and I subjects, namely the greater 
proportion of phospholipid and the smaller pro­
portion of protein can be interpreted as reflect­
ing the entry, in the former group, of overlipid- 
ated alpha lipoprotein carrying an even higher 
proportion of phospholipid than it normally trans­
ports# The present study demonstrated a marked 
increase in the phospholipid:cholesterol ratio of 
the HDL fraction, especially of the Group III 
subjects compared with normal alpha lipoprotein 
(Table 10*14), and Eder et al (l955) and Russ et 
al (1956) previously observed similar changes in 
the/
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the Cohn fractions which normally contain 
alpha lipoprotein* Although the composition 
of the beta lipoprotein within the LDL frac­
tion of the Group III subjects could not be 
established, it is likely that, on account of 
the severer degree of hyperlipidaemia in these 
subjects, it was distorted along similar lines 
to, but to a greater extent than, the beta lipo­
protein of the Group I subjects* The compos­
ition of the additional lipoprotein band found 
on paper electrophoresis of the LDL fraction of 
the Group III subjects and which, may represent 
the abnormal alpha lipoprotein, is in keeping 
with the above since the lipids predominating in 
it were lecithin and sphingomyelin, and free 
cholesterol*
An alternative explanation for the entry of 
alpha lipoprotein into the LDL range could be the 
formation of an abnormal complex between it and 
beta lipoprotein whose net density lay between 
1,006/
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1,006 - 1.063o No evidence of such coinplexing 
was found in the present study*
Electrophoretic Mohility of Abnormal Forms;
The variation in the electrophoretic mobility 
of the 2 forms of alpha lipoprotein requires 
explanation. Native alpha lipoprotein displays 
the electrophoretic mobility of an alpha^ globu­
lin, Evidence has been cited, in Chapter 1, for 
alpha lipoprotein being a constituent of pre­
beta lipoprotein. The faster electrophoretic 
mobility of pre-beta lipoprotein compared with 
beta lipoprotein has been suggested to be due to 
the contribution, to the former, of the negative 
charge of alpha lipoprotein (Levy et al, 1966),
The abnormal low density alpha lipoprotein 
detected in the Group III subjects showed altered 
electrophoretic mobility both in agar and agarose 
gels* Its probable counterpart on paper electro­
phoresis also showed a mobility quite different 
from that of normal alpha lipoprotein. Presumably 
the net surface charge of the lipoprotein has been 
reduced/
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reduced by the overlipidation of the molecule, 
especially by phospholipid; as has been out­
lined in Chapter 6, postulated molecular models 
of alpha lipoprotein place its normal comple­
ment of phospholipid at the surface of the 
complex* Alternatively the excess lipid may 
have led to conformational changes in the lipo­
protein and alteration in its surface charge*
A reduction in charge might also be related to 
the altered free cholesterol; cholesterol ester 
ratio (see below)*
Group II Subjects: The changes in the lipo­
proteins in the 2 subjects belonging to Group II 
merit special comment* Like the other jaundiced 
subjects they showed hypercholesterolaemia and 
hyperphospholipidaemia* The degree of this 
hyperlipidaemia placed them in an intermediate 
position between the subjects of the other groups.
Unlike the other subjects their free chol­
esterol: cholesterol ester ratio was normal, and 
their/
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their mean HDL cholesterol and phospholipid 
levels were significantly higher than those 
of Groups I and III and of the control sub­
jects, in keeping with the unusually promin­
ent alpha lipoprotein hands identified on 
paper electrophoresis of their plasma and 
HDL fraction.
These raised levels of HDL lipid may be 
due to a degree of hyperlipidaemia sufficient 
to overlipidate normal alpha lipoprotein, but 
insufficient to reduce the density of more 
than a fraction of the lipoprotein to below
1.063.
The normal electrophoretic mobility of this 
relatively small amount of alpha lipoprotein 
could then be attributed to an insufficient 
degree of overlipidation to significantly alter 
the net surface charge. The maintenance of a 
normal free cholesterolrcholesterol ester ratio 
by each of the 2 Group II subjects, despite an 
absolute increase in both components, is noteworthy. 
It raises the possibility that alterations in the 
electrophoretic/
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electrophoretic mobility of alpha lipoprotein 
occur only when this ratio is increased*
Source of Excess Lipid: Several sources
could account for the additional lipid which 
alters the composition of both the alpha and 
beta lipoproteins and increases the concen­
tration of the latter* It may accumulate 
secondary to the biliary obstruction and the 
release from the liver of the retained free 
cholesterol and phospholipid. Phospholipid, 
mainly in the form of lecithin (Nakayama and 
Blondstrand, 1961) constitutes about 82^ by 
weight of normal human bile and free cholesterol 
9^. Other lipids are present in only small 
amounts (Nakayama and Johnston, I962).
An additional or alternative source of 
lipid may result from enhanced hepatic synthesis; 
following the production of obstructive jaundice, 
in the rat, by bile duct ligation (Fredrickson et 
al, 195 )^ there occurs an increase in cholesterol 
synthesis/
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synthesis in the intact animal or by liver 
slices or homogenates, an observation recently 
confirmed by Weis and Dietschy (1969) who found 
biliary ligation to produce an increment, of 
two and a half to three times, in the rate of 
hepatic cholesterolgenesis.
An alteration in the activity of the leci­
thin; cholesterol acyl transferase (LCAT) enzyme 
might contribute to the accummulation of free 
cholesterol and lecithin. This enzyme catalyses 
the transfer to an acyl radical from the 2 pos­
ition of lecithin to the 3-hydroxyl of free chol­
esterol, the products of the reactions being 
lysolecithin and cholesterol ester (Glomset, 
1968)0 Studies on several affected members of 
a kindred with an apparent deficiency of the 
enzyme suggest that it is responsible for the 
formation of most of the cholesterol ester of 
human serum (Norum and Gjone, 1967)0 The 
enzyme may be associated, in the plasma, f^ith
hdl/
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HDL ( L o s s o w  et al, 1966) and it is possible 
that LCAT acts on lipid previously bound to 
HDL (Schumaker and Adams, 1969)* It may be 
synthesised in the liver (Brot et al, 1962). 
Impaired activity of the enzyme which has been 
reported to occur in liver disease (Simon and 
Scheig, 1970) might be expected to result in 
accummulation of lecithin and free cholesterol, 
especially in HDL. However, this seems to 
occur predominantly in parenchymatous liver 
disease rather than in obstructive jaundice or 
biliary cirrhosis in which the enzyme activity 
has been observed to be normal or high (Simon 
and Scheig, 1970) although contrary findings 
have been previously reported (Turner et al, 1953), 
Lipid Binding Properties of Alpha Lipoprotein:
The lipid-binding properties of alpha lipoprotein 
or its apoprotein indicate a potential for the 
overlipidation postulated to occur in the subjects 
in the present study.
The apoprotein of HDL has a strong affinity
for/
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for lipid, and HDL itself might he capable 
of binding more lipid than it normally 
carries, especially free cholesterol and phos­
pholipid. For example, native HDL was shoivn 
to combine with a wide variety of lipid 
molecules when they were dispersed with Celite 
(Ashworth and Green, 1963)0 Much larger 
amounts of free sterol than sterol ester could 
be introduced* Scanu and Hughes (1960) and 
Scanu and Page (1961) labelled the apoprotein,
obtained following almost complete delipid«»
131at ion of HDL, with I and showed that, when 
added to whole human serum, it yielded a 
labelled complex displaying the ultracentrifugal 
and electrophoretic characteristics of normal 
HDL. Subsequently Scanu (196?) showed human 
apoprotein A to recombine with aqueous dis­
persions of lecithin, phosphatidyl ethanolamine 
and sphingomyelin in an energy-free system 
suggesting non-covalent bonds between the protein 
and/
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and phospholipid* The avidity of the protein 
for lipid seemed to reside in the primary 
structure of the former since it was retained 
even when the alpha helical structure of HDL 
had been completely unfolded by the presence 
of urea (Scanu, 1965).
A greater affinity of delipidated human 
LDL for phospholipid and free cholesterol 
than for triglyceride and cholesterol ester 
was found by Sohdi and Gould (1967)0 Control 
experiments with other plasma proteins showed 
no such lipid-binding suggesting that the 
affinity of apoHDL for phospholipid and chol­
esterol was a specific property of the apo- 
lipoprotein* This affinity for phospholipids 
may also be reflected by the difficulty with 
which they may be removed from alpha lipoprotein 
compared with other lipids in delipidation pro­
cedures (Fredrickson et al, 1967)0 The probable 
presence of HDL in chylomicrons may also indicate 
the/
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the affinity of HDL for lipid (Fredrickson et 
al, 1967)0
It has further been suggested that 
phospholipids have the property of stabilising 
lipoproteins so that their capacity for chol­
esterol binding is increased (Ahrens and 
Kunkel, 1949)#
CHAPTER 12
"FLOATING" BETA LIPOPROTEIN 
IN OBSTRUCTIVE JAUNDICE
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A lipoprotein of beta mobility on paper 
electrophoresis at d < 1#006 was described for 
many of the jaundiced subjects. Chapter 12 
discusses this finding and its possible cause.
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A lipoprotein with beta mobility on paper 
electrophoresis was found in the d < I.OO6 frac­
tion of subjects belonging to each of the 3 groups, 
as indicated in Chapters 5, 7 and 9o In this 
abnormal property it resembles the "floating" beta 
lipoprotein which defines familial Type III hyper- 
lipoproteinaemia (Fredrickson et al, 1967)© It 
was present in the VIDL fraction of 6 of the 10 
Group I subjects, 1 of the 2 Group II subjects and 
4 of the 9 Group III subjects* Only 3 of the 
subjects, all of Group III, showed the "broad beta" 
band usually, but not invariably, seen on lipoprotein 
paper electrophoresis of the whole plasma of sub­
jects with familial Type III hyperlipoproteinaemia* 
Almost all the subjects, including those with 
raised triglyceride levels lacked a distinct pre­
beta or a chylomicron band, suggesting that normal 
or excess levels of triglyceride were transported 
predominantly in this abnormally light beta lipo­
protein form*
The/
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The changes leading to this acquired form of 
"floating" heta lipoprotein can only he conjectured 
at this stage* In Type III hyperlipoproteinaeraia 
the basic biochemical defect is unlmoim. In 
Tangier Disease or Familial Alpha Lipoprotein 
Deficiency (Fredrickson, 1966) a hereditary and 
complete deficiency of normal alpha lipoprotein is 
also associated with the presence of some beta- 
migrating lipoprotein at d < 1,006. Alpha lipo­
protein, with beta lipoprotein, is a normal com­
ponent of pre-beta lipoprotein (Levy et al, 1966) 
and may, by the contribution of its negative charge, 
be responsible for altering the mobility of the 
complex from beta to pre-beta* Its absence in 
Tangier Disease may determine an inability to form 
normal pre-beta lipoprotein complexes. Instead 
the VLDL fraction would contain a complex which 
retained beta mobility (Levy et al, 1966)*
Although alpha lipoprotein was present, to 
an apparently variable extent, in all the jaundiced 
subjects/
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subjects it varied in density and electrophoretic 
mobility in Groups II and III, and in all groups, 
in its lipid composition or concentration. It 
is possible that this abnormal alpha lipoprotein 
is incapable of participating in normal pre-beta 
lipoprotein complexes. Alternatively, it may be 
present in the pre-beta complex, but, because of 
a decreased negative charge or an altered struc­
tural relationship with the other components of 
the complex, it fails to confer on it a pre—beta 
mobility*
Resolution of this problem awaits more 
detailed studies of the VLDL fraction of the 
jaundiced subject*
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CHAPTER 1
TABLE 1.1
OPERATIONAL CLASSIFICATIONS OF PLASMA LIPOPROTEINS
Paper Preparative
Electrophoresis XJltracentrifuge
Chylomicrons
Beta
Pre-heta
Alpha
Chylomicrons
(a < 0.95)
Low density (LDL)
(a 1.006 -  1.063)
Very low density
(vld l)
(a 0.95 -  1. 006)
High aensity (h d l) 
(a 1.063 -  1. 21)
Analytical
Ultracentrifuge
S * > 400I
S^ 0 - 20
S^ 20 - 400
Sediments at
a 1,063
* S^ unit = Svedherg unit of flotation expressed In 
10"^^ cm/sec/dyne/C (in solution of 
NaCl of d 1.063 and temperature 26°)
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TABLES 
CHAPTER 3
TABLE 3ol
AGE, SEX AND DIAGNOSIS OF SUBJECTS STUDIED 
Subject Age Sex Diagnosis
noo
1 32 M biliary cirrhosis
2 39 M post-necrotic cirrhosis 
progressing to intra- 
hepatic cholestasis
3 37 M biliary cirrhosis
4 ' 42 F biliary cirrhosis
5 45 M biliary cirrhosis
6 15 F biliary cirrhosis
7 39 M stone in common bile duct
8 48 M stone in common bile duct
9 49 F intrahepatic cholestasis
10 38 F biliary cirrhosis
11 50 F biliary cirrhosis
12 65 F biliary cirrhosis
13 41 M biliary cirrhosis
14/
TABLE 3.1 (oontd.)
14 51 F carcinoma of pancreas
15 45 M biliary cirrhosis
16 54 M carcinoma of pancreas
17 61 M carcinoma of pancreas
18 60 M biliary cirrhosis
19 56 F biliary cirrhosis
20 30 M stone in common bile duct
21 46 M Hodgkin^s disease with
glands in porta hepatis
TABLE 3a 2
SERUM BILIRUBIN AND ALKALINE PHOSPHATASE LEVELS 
OF SUBJECTS STUDIED
Alkaline phosphatase 
k!a : u^ ts
I . 8o9 12 B
2 4o2 48 K-A
3 3,8 24 B
4 4o8 80 K-A
5 2o3 96 K-A
6 lo2 88 K-A
7 2.0 38 K-A
8 8o0 74 K-A
9 2.9 22 B
10 8.4 80 K-A
11 9.2 66 K-A
12 2.3 67 K-A
13 13.8 34 B
14/
TABLE 3.2 (oon-fcd.)
14 15.6 53 K-A
15 3.9 48 K-A
16 30,0 50 K-HV
17 14.9 73 K-A
18 25.8 17 B
19 22,0 > 50 K-A
20 6.8 22 B
21 7 .0  70 K-A
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TABliE 5c 2
PHOSPHOLIPID COMPOSITION OF »SLOW^ > AND 
BETA LIPOPROTEIN BANDS FROM LOW DENSITY 
LIPOPROTEIN FRACTION OF SUBJECT NO. l6
Lecithin 
Sphingomyelin 
Lysolecithin 
Other phospholipids
^ of total phospholipid 
in hand
Slow
74.1
14.7
5.2
6.1
Beta
79o3
10.9
4.4
4.4
$ of total LDL phospholipid ._ 
in Slow hand
TABIES 
CHAPTER 10
og
I
I
oa
oiH
rH (d
g I 
g S
I
COs
o
e QQ0)
rH
%
O
otn
IT\
VO
o
iH
H
O rH
m
H
o
o
o
rH rH
O
rH
(H O
•H
rH m
oM
CO rH
•HO o o
•H
iH
CO o
iH
H
001 
rHO
rH
O
m
o
r\
o
o
VO
o
t
o
o
a
o
a
OOJ
o
00
O
oCv
o
Î
o
o
CM
I
o
o\tn
lOi
00
©
o
r\
o
o
00
m
I
m
o  o  
in VO
iH rH
I
o
o
rH
tn
I
o
m
ov
s
in
00
o
IH
CM
O
00
o
o
rH
Oov
t
o
om
m
I
o
VO
<ys
in
o
in
03
§
•H
•S
u
*s
o
o
§o
o
u
o
■ p
03
o
rH
O
0
1
ëCH
-&03o
s
ra
03
ë
8)
O
ë
to
03
O
fl
03
k
03
«H
«H
•Hro
M
03
CO
T3
%•H
o tH O m o iH tn o \ O tn03 00 l> m tn CT\ o o r - CM G\
P-i m tn CM CM CM O tnm
o
S
CM«
OtH
S 1
to o
EH Og 1
C3
'X!•H
ë
I
•H
a
tQ0)U
O
g
iH 00 m ON CM CM r- VO tH CM00 m m m m ON ON m 00
rH iH CM tH tH IH CM
DQ -P O iH 00 KN ON VO 00 CM•P OQ r- o 00 00 vo O
tH 0) tn tn tn CM tH CM iH tn vo m
-poo •*1-3 o
rQ fl
g
CM m  vo 00 OV
H
I
&
H
H
I
â
CM CM 00 CM V O i n ov o in
CM CM CM VO i n CM m rH
m IT\ O CM rH l> 1 in tn V O
GO CM 00 00 o o\ o CM O Otn . i n o ov r- o ov tn O 00
rH rH CM tn VO CM rH rH rH rH
*P
O
VO
CM
CM
o
oot—1 cS
m
r-I
nMMMH
CM OJ 
^  VD
CM
tnI—Ir\
00 ov
rH
O
CM
rH
CM
03
rH0 U
1
o
o\ tn CM O 00
CM o VO rH -4^
CM CM rH CM IH
-=i*
CM
tn inG-\ O00 CM
rH VO CM 00
OV in in OV
rH rH rH rH rH
CO
r40u
1
Ü
o o
•H rH CM 00 CM in
P4
•H
rH -T tn 00 -4^
O O in Ov tn
pQ rH tn CM
A
CO +  1 +  I + 1 +  1 + 1o
tn CM VO VO o
ÇLi o\ CM 00 intn in r- in rH
tn
I
a
o0
1
CQ
(Ü
§
•H
•g
Ïra
ra
g'"Os
%
ra
§
§
I
CO
-prH
|j
CO<D
o O iH
9 ra rH CM CM in
ns •H
cu U
•H <y tn cv iH tn inp CM in VO in 00
tn iH H rH
-p rH
CO bD +  1 + 1 +  1 +  I +  1
•tH
CO IH n- VO VO o tn
"p EH G\ ov 00 o CM
Ü iH CM CM rH<y•rn
'S
CO
«H
O
u
QJ
rQ
o
•p
u
0)4H0)
tn
•I(3UrQ
"o" rH
rH rH CM CT\ CM in
O
u .
, o in -4< iH iH4» .4^ 00 VO CM
CO rH rH iHo
iH +  1 +  Ï +  1 +  1 + I
O
rQ o \ CM iH 00
O CT\ in cn VOtn tn ‘ tn rH
r
S
M MM
H >
>
0)
H IH o
H
§
+ CO o
H iH •H
H H O 4H
IH M U •H
+
H
1
o
a
•H
CO
CM tn CM o -4 tn tn
m 00 rH •4 -4 rH vo tn tn
rH tn VD rH tn -4^ rH rH O 00 o (7\ CM
CM o O O o O O O O tn o VD O
9 # • # 0 • 9 • # • • *
rH o tn O o O tn O tn o tn o CM O
A V A V V V V
oro
1O
tn 
o
-4* vo CT\ 00 -4 a\
tn O tn ■ VO r' tn
vo tn r- tn vo tn O in OV tn CT\ tn rH ino o o CM o CM o tn o m o tn o
» 9 • 0 # • # • 9 • # •
rH O o o rH o iH o o O tH o tH o
A A A A A A A
vo -4 00 vo CM tn
tn tn tn tn rH 00 vo
tn tn tn tn r- CM O tn iH rH tn
tn o tn o o vo O VO O tn O iH o
• • • • 0 « • « # • # • 9
o o tH o o o CM O o tn o ; tn O
A A A V V V V
m
Q)o
§
o
•H
«H
•H
a
•H
1/3
A A A CH
M
H
H
H
H
t
M
H
H
M
M
H
f
M
-P
M
M
P4 -P A
M
M
H
a
H
H
H
PH
H
M
4
H
'a
o0
1
t3
«
-gpCH
rQE
9Ü0)
p
00 00 1—1 tn m CM O VO
00 o r- tn tn tn O iH
CM tn tn iH rH
vo
-4<
CM
CM VO tn -4 00 o\ O 0\ tn
-4 P CM CM iH O CM
CM tn rH -4*
0
o
Eh
t/3
EH
P
S«H
OO<u
p
o 00 CM CM 00 . O o 00 CM
-f VO rH CM CM vo vo rH
vo CM o tn • rH tn
O
rH 00
a
o
0 rH
fi
fi
•• fi
tH fi
rH
O
fi
fi
•P
OQ
Iz;
O -P O -P fi
A fi CQ fi fi rH
H M ■ <D fi fi fi O
P CD ns •P *P P
a
tH iH T) •H CQ iH CQ iH O
O ■r^ P fi O fi O
0 fi fi •H iH fi rH fi Q<ri o <D CD OJ rH O fi O fi •H
A fi O •P p O P •P P  *P fi
*H CQ P O fi . O  CQ •P
•P ro CD iH P fi fi O
O iH bD CQ fi (H fi iH fi
p o O •H O fi O fi O P•1—, fi P fi P fi P fi P O
rQ 'IH O -P P «H O =H O p.
fi *r-t
CO rH
Q P
Q o
bD
P •p
cci cda -p
1 ‘rip p vol
•H •rH iHfi O
(d fi
P fi Ofi P PP
-P
P
Ofi
S •t-i
1
I
o 00 tn m in CM o -4 VOtn ov 00 CM o VO -4< rHtn rH tn fH CM CM
A
i
9
I
VO o 00 rH in in 00 00 o
vo vo CM 00 00 M o rH
in rH
n
rH
in
00
CM tn
9
1O
g
I
VO CM •4" -4 CM CM O 00 00
CM iH O IN rH
in VO o
rH
in
00
00
CM tn
4» VO o in OV in o in rH
-4 n- CM o in r- rH vo .4 CM• 4 in vo rH •4 rH tn
O 9 in
rH fi rH 00
Eh
f i ## fipH fi rH CD
O 4) O 43
f i CQ f i CQfi CD CD CD
VO CD *P 4>rH rH •H CQ rH COrH
O •rH P CD O CD O9 fi f i •H rH U rH uo! CD (D CD rH O 0) O CD
p o -P P O P -P P -P
•iH CQ P O CQ O CQ43 a 0> rH P CD CD
O rH bS} CQ CD rH CDI—(CD O •H O CD O <D O•r-: CÜ P fi P fi P fi P
P •IH o 4> P «H O «H o
m
o
fi0»
•pmQ
rHO
PO
0•HfiHHO
fiPO
P•H
rH
CDCQCD .
P Pc3 ObD•H
P 43(d cd
a 4=[•H
p P•rl•iH
u Ocd CD
P IHCD P
P
P
TABLE 10.9
NORMAL UPPER LIMITS PGR SERUM PHOSPHOLIPID LEVELS
levels (nig/lOO ml) calculated from data of Adlers- 
berg et al (1956) as mean + 2 standard deviations
Age (years) Males Females
1 3 - 1 7  186 192
18 -  22 209 210
23 -  27 214 214
28 -  32 259 209
33 -  37 243 216
38 -  42 259 234
43 -  47 248 253
4 8 - 5 2  250 268
53 -  57 255 303
58 -  62 254 293
62 -  67 276
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TABLE 10.8
NOBMAL LIMITS FOR PLASMA FREE CHOLESTEROL 
AND CHOLESTEROL ESTER LEVELS
limits (mg/lOO ml) calculated from normal limits 
for total cholesterol (Table lOol) and taking 
free cholesterol:cholesterol ester as 1:2
Age (years)
free cholesterol
cholesterol ester
0 - 1 9  40 - 77 80 - 154
20 - 29 40 « 80 80 l60
50 - 39 47 « 90 94 « 180
40 - 49 50 - 103 100 « 206
50 «  59 53 «  110 106 -  220
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FIGURES 
CHAPTER 4
Lep:end f or .Fi^ o^ 4pJL
DIAGRAMMATIC REPRESENTATION OF 
ELECTROPHORETIC MOBILITIES OF PLASMA 
LIPOPROTEINS IN AGAR AND AGAROSE GELS
It should be noted that
(a) beta lipoprotein hardly migrates in agar 
and tends to react vith the gel.
(b) pre-beta lipoprotein is not distin­
guishable from beta lipoprotein in agar 
but has an independent mobility in 
agarose.
alpha
pre-beta
beta
2%AGAR. 1% AGAROSE.
Legend for Fig# 4q2
IMMÜNOELECTBOPHORESIS OP NORMAL PLASMA 
IN AGAR GEL
The antisermn in the left-hand trough vas 
R5 vlth anti-alpha and anti-heta lipoprotein 
reactivityo
The antiserum in the right-hand trough 
vas Hyland anti—beta lipoprotein antiserumo 
The appearances, vhich are typical of 
normal plasma, produced vith R5 are of a beta 
lipoprotein precipitin arc vhich has hardly 
migrated from the origin, and a faster moving 
alpha lipoprotein precipitin arc. The mono- 
specific anti-beta lipoprotein antiserum has 
reacted vith the beta lipoprotein only*
Some beta lipoprotein has typically inter­
acted vith the gelo Very lov density lipo­
protein is not distinguished from beta lipo­
protein vith this system*
In/
In this slide and in all the other inuntmo- 
electrophoretic investigations vhich are sub­
sequently described, all precipitin lines vhich 
are held to be due to lipoprotein vere sho^m to 
stain for lipid vith Oil red 0*

Legend for Fig. 4*3
IMMUNOELECTROPHORESIS OP PLASMA IN AGAR GEL 
SHOmNG ADDITIONAL PRECIPITIN LINE
Plasma samples from subject no. 20*
The left-hand trough in each slide vas 
loaded vith antiserum R5 vith anti-alpha and 
anti-beta lipoprotein reactivity. Each right- 
hand trough contained Hyland anti-beta lipo­
protein antiserum*
In A and B (samples of May 13th) the 
plasma has reacted vith R5 to produce normal 
beta and alpha lipoprotein precipitin arcs, 
and a 3rd arc vhich has migrated slightly 
tovards the cathode. The additional arc has 
not been seen, by R5, in slides C (sample of 
May 29th) or D (sample of June 10th).
The additional arc has also not been 
produced by the monospecific anti-beta lipo­
protein antiserum.
»' C r '
Legend for Pig* 4o4a
IMMUNOELECTROPHORESIS OP PLASMA IN AGAR GEL
SHOmNG PRODUCTION OF ADDITIONAL PRECIPITIN
ARC BY SEVERAL ANTI-ALPHA LIPOPROTEIN ANTISERA
Plasma of subject no* lA (Dec* 27th)o 
The troughs vere loaded vith the follov- 
ing antisera reading from left to right 
A 79, 81 B R5, alpha L Tp d.
C ABS, Hyland anti-beta D R3, 51
Antisera R5 and 51 have each reacted vith
the plasma to produce a sharp nev precipitin
arCo The arc is faintly seen for antiserum 
R3 and possibly for AES* Only a beta lipo­
protein precipitin arc vas obtained vith the 
monospecific Hyland anti-beta lipoprotein 
antiseruuio

°Legend for Fig, 4.4b
IMMUNOELECTROPHORESIS OF PLASMA IN AGAR GEL 
SHOmNG PRODUCTION OF ADDITIONAL PRECIPITIN 
ARC BY SE\rERAL ANTI-ALPHA LIPOPROTEIN ANTISERA
Plasma of subject no. 14 (Dec. 27tb).
The troughs vere loaded vith the follov­
ing antisera reading from left to right 
A Rl, 51 B 124A, 360
C alpha LpT^, R2 D EGA, ZAZ 2
Antisera Rl, 51, 124A, alpha LpT^ and R2 
have each reacted vith the plasma to produce 
the nev cathodal-migrating precipitin arc*
It has not been produced vith the monospeci­
fic anti-beta lipoprotein antiserum 3^0.
A dense material vhich has reacted vith 
the gel is seen internal to the nev precipitin 
arCo
• i
Legend for Fig* 4*5
IMMUNOELECTROPHORESIS OF HIGH DENSITY 
LIPOPROTEIN FRACTION IN AGAR GEL FROM 
SUBJECT m T H  ADDITIONAL PRECIPITIN ARC 
IN LOW DENSITY LIPOPROTEIN FRACTION 
SHOWING NOmiAL ALPHA LIPOPROTEIN 
PRECIPITIN ARC ONLY
A Fraction of subject no* 14 (Dec*
27tb)o
The antiserum in each left-hand trough 
was monospecific Hyland anti-beta lipoprotein 
antiserum and in each right-hand trough R5 
vith anti-alpha and anti—beta lipoprotein 
reactivity© Normal alpha lipoprotein precip­
itin arcs have been produced vith R5 but there 
is no evidence of the additional precipitin 
arc seen in the corresponding lov density lipo­
protein fraction*
In B and C the high density fraction of 
subjects/
subjects nos. 1 and 4 respectively, -with no 
abnormal precipitin arc in their lov density 
fraction, vas run. It yielded, vith R5, a 
normal alpha lipoprotein precipitin arc in 
both cases.

Legend for Fig. 4.6
IMMUNOELECTROPHORESIS OF d > I.OO6
LIPOPROTEIN FRACTION IN AGAR GEL SHOWING
ADDITIONAL PRECIPITIN ARC
Fraction of A subject no, 14 (Dec. 14tb)
B subject no. 14 (Feb. 2nd)
C subject no. 15 
D subject no. 1?
The antiserum in each left-hand trough 
vas R5 and in each right-hand trough Hyland 
anti-beta. In A, C and D, in addition to the 
normal alpha lipoprotein and beta lipoprotein 
precipitin arcs, R5 has produced a cathodal- 
migrating arc. The monospecific Hyland 
anti-beta lipoprotein antiserum has resulted, 
for each sample, in a beta lipoprotein precip­
itin arc only. In B the fraction obtained 
follomng the relief of jaundice and the fall in 
plasma/
plasma lipids in subject no, 14 no longer shows 
the additional arc; instead the normal alpha 
lipoprotein precipitin arc vhich is faint in 
his earlier sample in A is more prominent*

Legend for Fig© 4*7
IMMUNOELECTROPHORESIS OF LOW DENSITY
LIPOPROTEIN FRACTION IN AGAR GEL
SHO\\nNG ADDITIONAL PRECIPITIN ARC
Fraction of subject no. 15,
The left-hand trough contained antisera 
R5 vith anti-alpha and anti-beta lipoprotein 
reactivity; a sharp precipitin arc vhich has 
barely migrated cathodally has been produced* 
The right-hand trough contained antiserum 3^0 
vith anti-beta lipoprotein reactivity only 
and no cathodal-migrating precipitin arc 
corresponding to that produced vith R5 is 
found* Both antisera have produced indis­
tinct beta lipoprotein precipitin arcs.

Legend for Fig* 4.8
IMMUNOELECTROPHORESIS OF LOW DENSITY
LIPOPROTEIN FRACTION IN AGAROSE GEL
SHObHNG ADDITIONAL PRECIPITIN ARC
Fraction of A subject no. 15
B subject no. 17
The antiserum in each right-hand trough 
vas the polyvalent antiserum AHS© In B only 
a normal beta lipoprotein precipitin arc has 
resulted; in A an additional arc is also 
visible, displaying an electrophoretic mobil­
ity close to that of the beta lipoprotein.
The ill-defined precipitate running through 
the centre of each slide can be ascribed to
the polyvalent antiserum AHS having reacted
vith components of the antiserum, ZAZ 2, 
vhich had been added to the left-hand trough.

Legend for Fig. 4.9
IMMUNOELECTROPHORESIS OF LOW DENSITY
LIPOPROTEIN FRACTION IN AGAROSE GEL
SHOmNG ADDITIONAL PRECIPITIN ARC
Fractions of A subject no, 14 (Dec, 14th)
B subject no. 14 (Feb. 2nd)
C subject no. 15
D subject no. 17
The antiserum in each left-hand trough was 
79 with anti-alpha and anti-beta lipoprotein 
reactivity. In A and C in addition to the
beta lipoprotein precipitin arc produced by
the antiserum, a portion of an additional arc 
is present. The additional arc in the LDL 
fraction in A is no longer evident in the same 
subject*s low density lipoprotein fraction in 
B obtained when the jaundice had been relieved, 
A beta lipoprotein precipitin arc only is seen 
in D though an additional arc was seen in agar.

Legend for Fig. 4*10
IMMUNODIFFUSION OF LOW DENSITY LIPOPROTEIN
FRACTION IN OUCHTERLONY PLATE SHOWING
. ADDITIONAL PRECIPITIN LINE
The centre wells of A and B contained anti- 
seruui 124A with anti-alpha and anti-heta lipo­
protein reactivity©
The centre wells of C and D contained the 
monospecific anti-heta lipoprotein antisernm 
360©
The peripheral wells were loaded with low 
density lipoprotein fraction of
1. subject no. 14 (Dec© 14th)
2© subject no© 14 (Feb. 2nd)
3. subject no© 15
The top and bottom wells in each series 
contained low density lipoprotein from a normal 
subject.
The/
The remaining wells contained low density 
lipoprotein from other subjects in the series.
The fraction in 1 and 3 has reacted with 
antisertmi 12^ iA to produce 2 precipitin lines; 
the inner line shows a reaction of identity 
ifith the lines derived from the low density 
lipoprotein of both the normal and the other 
jaundiced subjects© The additional line in 
1 and 3 has not been produced by antiserum 
360, which has resulted in a single line giv­
ing a reaction of identity with that of normal 
beta lipoprotein. In 2 the fraction derived 
from subject no. 14 following relief of 
jaundice, no longer shows the additional line 
with antiserum 124A©
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Legend for Fig, 4.11
IMMUNOELECTROPHOEESIS OF PLASMA IN AGAR 
GEL SHOTONG DISAPPEARANCE OF ADDITIONAL 
PRECIPITIN ARC FOLLOMNG RELIEF OF 
OBSTRUCTIVE JAUNDICE
Plasma of subject noo l6
A Marg 7tb B Mar* 11th
C Mar* 20th D Mar. 29th
The antiserum in each left-hand trough 
was R5 with anti-alpha and anti-beta lipo­
protein reactivity, and in each right-hand
trough was Hyland anti-beta lipoprotein. In 
A, B and C the posterior spur of the addition­
al cathodal-migrating precipitin arc has been 
produced with R5, together with dense material 
which has reacted with the gel. Faint normal 
alpha lipoprotein precipitin arcs are also 
present. The plasma in D taken when the 
jaundice had been relieved and the plasma 
lipids/
lipids had fallen considerably, no longer 
shows the additional arc or the gel-reacting 
material with antiserum R5, but shows the 
reappearance of a normal alpha lipoprotein 
arc* The monospecific Hyland anti-beta 
lipoprotein antiserum has produced, in all 
cases, a single beta lipoprotein precipitin 
arc* See Table 10*4 for corresponding 
plasma lipid levels*
. &«/ .-hL
Legend for Fig. 4,12
IMMUNODIFFUSION OF LOW DENSITY LIPOPROTEIN
FRACTION IN OUCHTERLONY PLATE SHOWING 
DISAPPEAR/\NCE OF ADDITIONAL PRECIPITIN LINE 
FOLLOWING RELIEF OF OBSTRUCTIVE JAUNDICE
The centre wells contained the folloiving 
antisera reading from left to right and top to 
bottom
124A, 360, ZAZ 2, Hyland anti-beta,
RGA, Rl, R5, alpha L^T^, alpha L^T^,
AHS, 79, 81.
The first set of peripheral wells was loaded 
m th the low density lipoprotein fraction of 
1, subject no, 14 (Dec. 14th)
2o subject'no. 14 (Feb* 2nd)
3# a normal subject 
4, subject no. 15
The other sets of wells were similarly loaded.
In 1 and 4, 2 distinct precipitin lines 
have/
have been produced by several of the antisera, 
all of which have anti-alpha and anti-beta 
lipoprotein reactivity, but only a single line 
has been produced by the monospecific anti­
beta lipoprotein antisera 360 and Hyland 
anti-beta. In 2 and 3 a single beta lipo­
protein precipitin line has been produced by 
each of the antisera.

Legend for Fig# 4.13
IMMUNODIFFUSION OF LOW DENSITY LIPOPROTEIN 
FRACTION IN OUCHTERLONY PLATE SHOWING 
DISAPPEARANCE OF ADDITIONAL PRECIPITIN LINE 
FOLLOmNG REACTION \Y[TH ANTISERUM IVITH 
ANTI-ALPHA AND ANTI-BETA LIPOPROTEIN 
REACTIVITY, BUT NOT IflTH MONOSPECIFIC 
ANTI-BETA LIPOPROTEIN ANTISERUM
Fraction of subject no. 14 (Dec. 14th)# 
The centre well contained antiserum R5 
with anti-alpha and.anti-beta lipoprotein 
reactivity.
The peripheral wells were loaded as 
follows
1 and 2 supernate from 0.1 ml low density 
■ fraction diluted with saline two- 
and three-fold respectively.
3 and 4 supernate from 0*1 ml low density 
fraction previously reacted with 
0.2 ml/
0.2 ml and 0.3 ml antiserum 36O 
respectively (monospecific anti- 
beta lipoprotein antiserum).
5 and 6 supernate from 0*1 ml low density 
fraction previously reacted with
0.2 ml and 0.3 ml respectively of 
antiserum 124A (anti-alpha and 
anti-beta lipoprotein antiserum).
7 low density fraction from normal
subject.
Both saline-diluted fractions show 2 
precipitin lines (l, 2), The 2 fractions 
previously reacted with the anti-beta lipo­
protein antiserum 36O show removal of the 
internal precipitin line only (3, 4). The 
fraction previously absorbed with the larger 
volume of antiserum 124A shows removal of 
both precipitin lines (6).

Legend for Fig. 4.14
IMMUNODIFFUSION. IN OUCHTERLONY PLATE SHOWING- 
REMOVAL OF ANTI-ALPHA LIPOPROTEIN REACTIVITY 
FROM POLYVALENT ANTI SERUM FOLLOWING ITS 
REACTION m m  THE LOW DENSITY LIPOPROTEIN 
FRACTION OF A JAUNDICED SUBJECT
The centre well was loaded with high 
density lipoprotein prepared from a normal 
subject. The peripheral wells were loaded 
with
1. antiserum 81 2. antiserum 81 diluted to
equivalence with saline. 3, 4, 5 and 6 
supernates obtained following reaction of 0*1 
ml antiserum with 0,1 ml low density lipo­
protein from plasma of subject no, l6 of Mar, 
7th, Mar. 11th, Mar* 20th, and Mar. 29th 
respectively (see Table 10.4 for correspond­
ing plasma lipid levels).
In 1 and 2, the undiluted and diluted 
antiserum has reacted with the normal alpha 
lipoprotein/
lipoprotein to produce a precipitin line. In 
3 and 4, the antiserum has not produced this 
line, and in 5 it has produced a faint line 
only, A dense precipitin line is seen in 6 
indicating no significant removal of anti­
alpha lipoprotein reactivity from the anti­
serum hy the low density fraction of Mar, 29th 
when the plasma lipids had fallen substantially 
and the abnormal arc seen on Immunoelectrophor­
esis had disappeared.
An additional precipitin line is observed 
betwen 1 and 6, and between 2 and 3; it 
results from antiserum 81, which has kno^ vn 
anti-beta lipoprotein reactivity, in wells 1 
and 2 reacting with the beta lipoprotein of the 
low density lipoprotein fraction in wells 3 and 
6.

Legend for Fig* 4*15
IMMUNODIFFUSION OF ETHER-DELIPIDATED
LOW DENSITY LIPOPROTEIN FRACTION IN 
OUCHTERLONY PLATE
The antiserum in the centre well was 124A 
with anti-alpha and anti-beta lipoprotein 
reactivity* The peripheral wells were loaded 
with 1* ether—delipidated low density 
lipoprotein (subject no* 15)
2o delipidated high density lipo­
protein from a normal subject*
3o low density lipoprotein from a 
normal subject.
In 1 there is a beta lipoprotein precipitin 
line giving a reaction of Identity with the beta 
lipoprotein line in 3 (this was better seen by 
visual inspection of the plate)© The line 
formerly seen peripheral to the beta lipoprotein 
line/
line (see Fig* 4*14) in 2 is no longer evident* 
The inner line in 1 gives a reaction of partial 
identity with the delipidated normal high 
density lipoprotein in 2*
%5#
Legend for Fig, 4.l6
IMMUNOELECTROPHORESIS IN AGAROSE GEL OF 
ETHER-DELIPIDATED LOW DENSITY 
LIPOPROTEIN FRACTION
Plasma of subject no. 15.
The antiserum in each left-hand trough 
was R5 with anti-beta and anti-alpha lipo­
protein reactivity, and in each right-hand 
trough, Hyland anti-beta which is monospeci­
fic for beta lipoprotein.
In B the native low density lipoprotein 
has yielded, with Hyland anti-beta, a beta 
lipoprotein precipitin arc and, with R5, the 
additional arc.
In A the delipidated low density lipo­
protein fraction shows, with R5, a faint 
precipitin arc corresponding to the beta lipo­
protein arc produced with Hyland anti-beta, 
and a new faint lipoprotein arc with the 
approximate mobility of normal alpha lipo­
protein.

FIGURES 
CHAPTER 5
Legend for Fig. 5>1
LIPOPROTEIN PAPER ELECTROPHORESIS OF PLASMA
A, Plasma of subject no. 14 (load 20 jil) - 
shows a slightly prominent, sharply defined 
beta lipoprotein band and an absent alpha 
lipoprotein band* Despite a triglyceride 
level of 298 mg/lOO ml, there is only a 
slight pre-beta lipoprotein band*
Bo Plasma of subject no. 17 (load 20 jil) - 
shows a beta lipoprotein band of increased 
intensity and breadth, and of decreased defin­
ition resembling the "broad" beta band of Type 
III hyperlipoproteinaemia (triglyceride level 
249 mg/lOO ml)o The reproduction barely 
shows the faint alpha lipoprotein band which 
was present in the original paper strip*
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Legend for Fig 5.2
LIPOPROTEIN PAPER ELECTROPHORESIS 
OP d < 1.006 AND d > 1.006 FRACTIONS
Fractions of subject no. 14.
Ac d < I0OO6 fraction Load 40 jil
B, d > 1*006 fraction Load 20 p.1
The d < 1.006 fraction contains lipo­
protein of similar mobility to the beta lipo­
protein in the d > 1.006 fraction. Some 
"trail" is seen running from it to the origin*
œ
Legend for Fig, 5*3
LIPOPROTEIN PAPER ELECTROPHORESIS 
OF d > 1*063 FRACTION
A Subject no* 14 (load 40 jil) — shows absence 
of alpha lipoprotein band*
B Subject no, 17 (load 40 pi) — shows faint 
alpha lipoprotein band*
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Legend for Fie, *^4
LIPOPROTEIN PAPER ELECTROPHORESIS 
OF LOW DENSITY LIPOPROTEIN FRACTION
Subject no. I? Load 40 yil
A single well-defined beta lipoprotein 
band is présente

Legend for Figo 5o5a and b
PAPER ELECTROPHORESIS OF LOW DENSITY 
LIPOPROTEIN FRACTION 
DURING AND AFTER JAUNDICE
Fractions of subject no. l6 obtained 
during (Mar* 7th, 11th,• 20th) and after 
(Mar* 29th) jaundice.
The barbital buffer did not contain 
albumen to permit staining for protein* The 
upper strip of each pair was stained with Oil 
red 0 and the lower with bromophenol blue.
The samples obtained during the jaundiced 
phase all show a single beta lipoprotein band 
with the lipid stain, and an additional 
slower—migrating band with the protein stain. 
This band was subsequently shown to contain 
lipid*
The sample obtained following recovery 
from the jaundice showed only a beta lipo« 
protein band with either stain.
The omission of albumen from the buffer 
has resulted in bands which are not sharply 
defined*
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Legend for Pig* 5*6
PAPER ELECTROPHORESIS OF LOW DENSITY 
LIPOPROTEIN FRACTION
Fraction of subject no. 15*
Albumen was omitted from the barbital 
buffer to permit staining for protein. 
Corresponding strips, each of which had been 
loaded with 40 ;al of the fraction, were 
stained with A Oil red 0, and B bromo­
phenol blue.
In addition to a beta-migrating band 
produced with either stain, a cathodal- 
migrating band is seen. It stained better 
for protein than for lipid.
The omission of albumen from the buffer 
has resulted in bands which are not sharply- 
defined.

Legend for Fig. 5.7
THIN LAYER CHROMATOGRAM OF NON-POLAR LIPIDS 
OF EXTRACT OF "SLOlf* BAND 
FROM LOW DENSITY LIPOPROTEIN FRACTION
The non-polar lipid standards were - 
CE = cholesterol ester, FC = free cholesterol, 
TG = triglyceride.
The slow hand from the low density lipo­
protein fraction of subject no. l6 (Mar. 11th) 
contained non-polar lipid, predominantly free 
cholesterol together with a faint amount of 
cholesterol ester. In the original plate a 
very faint amount of triglyceride was also 
seen.
Details of the non-polar solvent system 
are given in Chapter 3o The plates were 
stained with anisaldehyde.

Legend for Fig. 3*8
THIN LAYER CHROMATOGRAM OF NON-POLAR LIPIDS 
OF EXTRACT OF "SLOW AND BETA BANDS 
. FROM LOW DENSITY LIPOPROTEIN FRACTION
Fraction of subject no. l6 (Mar* lltb).
L a lecithin S = sphingomyelin
The slow band from the low density lipo­
protein fraction produced a prominent lecithin 
and a faint sphingomyelin spot. The beta 
band produced a weaker lecithin spot and a 
very faint sphingomyelin spot, which does not 
show up in the print* The spots at the top 
of the plate are due to non—polar lipid*
Polar lipid standards were concurrently run. 
Details of the polar solvent system are 
given in Chapter 3* The plates were stained 
with anisaldehyde.
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Legend for Fig. 5.9
THIN LAYER CHROMATOGRAM OF NON-POLAR LIPIDS.
OF EXTRACT OF BETA LIPOPROTEIN BAND 
FROM LOW DENSITY LIPOPROTEIN FRACTION
The non-polar lipid standards were - 
CE - cholesterol ester, FC = free cholesterol, 
TG = triglyceride, FFA = free fatty acid.
The beta band from the low density lipo­
protein fraction of subject no. l6 (Mar. llth) 
contained non-polar lipid consisting of chol­
esterol ester, free cholesterol and trigly­
ceride#
Details of the non-polar solvent system 
are given in Chapter 3* The plates were 
stained with anisaldehyde.
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FIGURES 
CHAPTER 7
Legend for Fig. 7#1
LIPOPROTEIN PAPER ELECTROPHORESIS OF PLASMA 
FROM SUBJECTS m m  OBSTRUCTIVE JAUNDICE
The strips from A subject no. 1 and 
B subject no 5 were each loaded with 20 jil 
of plasma. They show lipoprotein bands of 
beta mobility which are of increased or normal 
intensity respectively* They show either faint 
or absent bands with the mobility of alpha lipo­
protein.
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Legend for Fig, 7.2
LIPOPROTEIN PAPER ELECTROPHORESIS 
OF LOW DENSITY LIPOPROTEIN FRACTION 
FROM 3 SUBJECTS WITH OBSTRUCTIVE JAUNDICE 
AND A CONTROL SUBJECT
A, B and C* Each was loaded with 40 )il of 
low density lipoprotein fraction from subjects 
no, 1, 2 and 3 respectively. Each shows a 
single intense lipoprotein band of beta 
mobility which may be contrasted with D, the 
single less intense band from the fraction of 
the control subject. Since twice the usual 
load was applied, to reveal any abnormal lipo­
protein band that might be present, the beta 
bands are more intense than usual.

Legend for Fig. 7,3
PAPER ELECTROPHORESIS OF LOW DENSITY 
LIPOPROTEIN FRACTION
Fraction of subject no. 9o
Albumen was omitted from the barbital 
buffer to permit protein staining.
Corresponding strips, each of which had 
been loaded with 40 pX of the low density 
lipoprotein fraction, were stained with A 
Oil red 0, or B bromophenol blue.
A single band of beta mobility is sho^m 
by either stain. The decreased sharpness 
of the bands is attributable to the omission 
of the albumen from the buffer.

Legend for Pi%, 7*^
IMMUNOELECTROPHORESIS OF LOW DENSITY 
LIPOPROTEIN FRACTION IN AGAROSE GEL FROM 
SUBJECTS m T H  OBSTRUCTIVE JAUNDICE
Fraction from A subject no. 2, and B 
subject no. 3o
The antiserum in each left-hand trough 
■was 79 f and in each right-hand trough 81.
A lipoprotein precipitin line of beta mob­
ility is observed in each case*
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Legend for Fig* 7.5
IMMUNODIFFUSION IN OUCHTERLONY PLATE OF 
LOW DENSITY LIPOPROTEIN FRACTION FROM 
SUBJECTS WITH OBSTRUCTIVE JAUNDICE
The antiserum in the centre well in the 
left-hand set of wells was 124A, and in the 
right-hand set, 3^0,
Each set of peripheral wells were loaded 
with the low density fraction from the follow­
ing subjects commencing with A and moving in 
a clockwise direction.
1, subject no. 1; 2. subject no. 2;
3o normal beta lipoprotein; 4, subject 
no. 3î 5o normal beta lipoprotein; 6.
B.R. (control subject); subject no. 5»
and 8. normal beta lipoprotein.
Each low density lipoprotein sample 
yielded with either antiserum a single pre­
cipitin line which gave a reaction of 
identity i/ith that from the normal beta lipo­
protein.

IMMUNODIFFUSION IN AGAR GEL OF LOW DENSITY 
LIPOPROTEIN FRACTION SHOmNG REMOVAL OF BETA 
LIPOPROTEIN BY ANTI^BETA LIPOPROTEIN ANTI SERA
Each set of peripheral wells was loaded as 
follows commencing with well A and moving in 
an anti-clodnfise direction*
A low density lipoprotein fraction of given 
subject;
B 0*1 ml loif density fraction diluted with 
0.1 ml EDTA-»saline;
C, D and E supernates from 0.1 ml low density 
fraction reacted with 0,03 ml, 0.08 ml or 
OolO ml respectively of a gamma—globulin 
preparation of antiserum 3^0;
F, G and H similar samples in which a gamma­
globulin preparation of antiserum 124A 
replaced the gamma—globulin preparation 
of antiserum 360,
The/
The four sets of wells occupying a 
horizontal row were used to study a given 
subject.
The subjects studied were row 1. no, 2, 
row 2. no, 3o
The antisera in the centre wells in a 
given row from left to right were 124A, 3^0, 
AHS, and 79.
The undiluted and saline-diluted low 
density lipoprotein fractions of each of the 
subjects has resulted in a beta lipoprotein 
precipitin line with each of the antisera.
This line has not been produced by the super­
nates from the fractions previously reacted 
with the maximum amounts of either of the anti- 
sera.
% r
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IMMUNOELECTROPHORESIS IN AGAR GEL SHOWING 
ABSENCE OF BETA LIPOPROTEIN PRECIPITIN LINE 
FROM LOW DENSITY FRACTION FOLLOWING REACTION 
m m  ANTI«BETA LIPOPROTEIN ANTI SERA
The centre wells were loaded with 
A " low density lipoprotein fraction diluted 
ifith 3 volumes of EDTA«saline from sub­
ject no* 8 from Group I (see text for 
definition of Group l).
B - supernate from this fraction reacted
with 3 volumes of antiserum 36O (anti« 
beta lipoprotein antiserum)*
C — supernate from this fraction reacted
with 3 volumes of antiserum 124 (anti- 
alpha lipoprotein, anti—beta lipoprotein 
and anti-albumen antiserum)*
All left-hand troughs were loaded with 
antiserum R3 and all right-hand troughs with 
Hyland/
Hyland anti—beta lipoprotein antiserum*
In A a beta lipoprotein precipitin 
arc, of reduced intensity because of the 
saline dilution, is seen with either anti— 
serum* The arc is not seen in B or C 
indicating its prior removal by antisera 
360 or 124*
V
Legend for Fig« 7,8
PAPER ELECTROPHORESIS OF LOW DENSITY FRACTION 
SHOmNG ABSENCE OF BETA LIPOPROTEIN BAND 
FOLLO^NG REACTION m m  ANTI-BETA 
LIPOPROTEIN ANTISERA
Fraction of subject no. 3*
In A. the fraction has resulted in a normal 
beta lipoprotein band. This band is not present 
in either B* or C. which represent the fractions 
following their absorption with antisera 124A or 
360 respectively.
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Legend for Fig. 7.9a and b
THIN LAYER CHROMATOGRAM SHOmNG REMOVAL OF 
NON-POLAR LIPIDS FROM LOW DENSITY FRACTION 
FOLLO^NG ITS REACTION \fTTH ANTI-ALPHA 
AND ANTI-BETA LIPOPROTEIN ANTI SERUM
The subjects were 1* no* 1; 2* no* 2; 
3© no* 3 (all from Group I as defined in 
text); 4, B (control); and 5© no* 11 
(from Group II)*
A refers to sample derived from chloro­
form: methanol extract of supernate from 0*3 
ml low density lipoprotein fraction reacted 
with gamma—globulin preparation of antiserum 
124A, except for no* 2 where 0*5 ml of anti- 
serum was used*
0 refers to low density lipoprotein 
fraction diluted with corresponding volume of 
EDTA-saline*
Extracts of the corresponding EDTA-saline
dilutions of the antiserum (designated and
o30/
.5a/
were also run, as were the following
# 3A
non-polar lipid standards, FFA - free fatty 
acid, TG = triglyceride, chol - cholesterol 
(free and ester).
All extracts from saline diluted low 
density fractions show free and ester chol­
esterol, and triglyceride spots. The tri­
glyceride spots were faint in 4 and 5 and 
barely show up in the colour print.
The extracts from the antibody—treated 
low density fraction show removal of most of 
this lipid* The faint free and ester chol­
esterol spots which remain in lA, 3A and 5A 
are of similar intensity to those of the 
control subject (4A) and are found in the 
extract of the EDTA-saline diluted antisera 
(*„.); the spots remaining in 2A are similar
to those in the diluted antiserum (*%_) which
*
contains a larger proportion of the antiserum.
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Legend for Fig. 7,10a and b
THIN LAYER CHROMATOGRAM SHOWING REMOVAL OF 
POLAR LIPIDS FROM LOW DENSITY FRACTION 
FOLLOWING ITS REACTION WITH ANTI-ALPHA 
AND ANTI-BETA LIPOPROTEIN ANTI SERUM
The subjects were 1, no* 1; 2* no, 2;
3o no. 3 (all from Group I as defined in text); 
4o B (control); and 5© no. 11 (from Group II)* 
A refers to sample derived from chloro­
form: methanol extract of supernate from 0,3 ml 
low density fraction reacted with 0*3 ml anti- 
serum 124A, except in 2 where 0*5 ml of anti- 
serum was used*
0 refers to similar extract of low 
density fraction in which EDTA-saline had been 
added instead of the antiserum*
Extracts of corresponding EDTA-saline
dilutions of the antiserum (designated * . and 
50 \•^^) were also run, as were the following 
polar/
polar lipid standards; lysolec = lysolecithin, 
sphingo - sphingomyelin, PS = phosphatidyl 
serine, PE = phosphatidyl ethanolaraine, lec = 
lecithin,
The extracts from the saline—diluted low 
density fractions show lecithin, sphingo­
myelin, and phosphatidyl ethanolamine spots.
The extract from the low density fraction 
reacted with the antiserura show no lecithin 
or sphingomyelin spots; very faint phos­
phatidyl ethanolamine spots remain; a similar 
faint spot has heen produced hy one of the
saline-diluted antisera (*_.), and was also
• 5A
seen with the other diluted antiserum (*__)9 ^ A
although this has not shown up in the photo­
graph® in addition, the control low density 
fraction (4) also showed a faint PE spot after 
treatment m t h  the anti serum.
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FIGURES 
CHAPTER 9
Legend for Fig, 9.1
LIPOPROTEIN PAPER ELECTROPHORESIS
OF PLASMA
Sample of subject no. 11.
The strip shows an increased amount of 
lipoprotein of alpha^ mobility tending to form 
2 bands.
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Legend for Fig. 9.2
PAPER ELECTROPHORESIS OF LOW DENSITY 
LIPOPROTEIN FRACTION
Fraction of subject no. 12*
In addition to a normal beta lipoprotein 
band a faint band of approximate alpha^ 
mobility is present.

Legend for Fig. 9*3
LIPOPROTEIN PAPER ELECTROPHORESIS
OF HIGH DENSITY LIPOPROTEIN FRACTION
Fraction of subject no, 11.
The paper strip shows a pronounced alpha 
lipoprotein band.
m
Legend for Fig. 9.4
LIPOPROTEIN PAPER ELECTROPHORESIS
OF d < 1,006 AND d > 1,006 FRACTIONS
Fractions of subject no. 11.
A The strip of the d > 1,006 fraction 
(load 20 jal) shows alpha and beta lipoprotein 
bands.
B The strip of the d < 1*006 fraction 
(load 40 pi) shows a band of mobility close 
to that of the beta band in the d > 1.006 
fraction.

Legend for Fig. 9,5
IMMUNOELECTROPHORESIS IN AGAROSE GEL OF LOW
DENSITY LIPOPROTEIN FRACTION SHOmNG ALPHA
LIPOPROTEIN PRECIPITIN ARC OF NORMAL MOBILITY
Fractions of A subject no, 11,
B subject no. 1*
The antiserum in each left-hand trough 
was 124A -with anti-alpha and anti-beta lipo­
protein reactivity.
The antiserum in each right-hand trough 
was the monovalent anti-beta lipoprotein 
antiserum 360o
In A the low density fraction was reacted 
with antiserum 124A to produce a normal beta 
lipoprotein precipitin arc, and a faint pre­
cipitin arc of normal alpha^ mobility. This 
can be contrasted with the fraction in B 
which has produced a normal beta lipoprotein 
arc only*
The additional precipitin arc in A has 
not been produced with antiserum 3^0*
r:
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Legend for Fig. 9*6
IbiMUNODIPFUSION OF LOW DENSITY LIPOPROTEIN 
FRACTION IN OUCHTERLONY PLATE SHOWING DIS­
APPEARANCE OF ADDITIONAL PRECIPITIN LINE 
FOLLOWING REACTION IflTH ANTISERUM IflTH ANTI­
ALPHA AND ANTI-BETA LIPOPROTEIN REACTIVITY 
BUT NOT m m  MONOSPECIFIC ANTI-BETA LIPO­
PROTEIN ANTISERUM
Fraction of subject no. ll©
The centre well vas loaded with antiserum 
alpha LpT^ vith anti-alpha and anti-beta lipo­
protein, and anti-albumen reactivity.
The peripheral veils vere loaded vith 
samples of
1 and 2 - 0,10 ml lov density lipoprotein frac­
tion respectively diluted vith 0.15 
ml and 0*20 ml of saline.
3 - beta lipoprotein from a normal
subject*
4 - supernate of 0,10 ml lov density
lipoprotein fraction following 
reaction vith 0,20 ml Hyland anti­
beta lipoprotein antisera,
5 and 6/
5 and 6 - supernate of 0,10 ml lov density 
lipoprotein fraction following 
reaction with 0,15 ml and 0,20 ml 
of antiserum 124 respectively.
7 and 8 - supernate of 0.10 ml lov density 
lipoprotein fraction following 
reaction vith 0,15 ml and 0.20 ml 
of antiserum 360.
1 shovs the least diluted fraction to con­
tain 2 immunoprecipitin lines# In 2 the 
fraction has been diluted so that the lines 
are not evident, 7 shovs that the fraction 
which had been reacted vith a volume, equal to 
that of the saline in 1, of the monospecific anti­
beta lipoprotein antiserum 360, contains the 
inner line only, the outer line having been 
removed. The excess of antiserum 36O in 8 
has reacted vith the lov density lipoprotein in 
1 to produce a precipitin line which gives a 
reaction of identity vith the outermost of 
the/
the 2 lines from 1, establishing this outer 
line to be due to beta lipoprotein, 5 shovs 
both lines to have been removed following 
reaction vith antiserum 124 vith anti-alpha 
and anti-beta lipoprotein, and anti-albumen 
reactivity* The precipitin line between 4 
and 5 is due to the excess of antiserum 124 
reacting vith an antigen derived from the 
material loaded in 4* This line gives a 
reaction of identity vith a faint line 
between 4 and the centre veil*
An identical picture is produced when 
other antisera \^d.th no anti-albumen react­
ivity vere used to load the centre veil.
The 2 precipitin lines in 1 may be 
contrasted vith those in the low density lipo­
protein fraction of subject no* 14 in Fig 
4ol5o There the additional line is peripher­
al to the beta lipoprotein precipitin line* 
Here it is internal to it*
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